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1. INTRODUCTION  
1.1 Inflammation 
Inflammation has been recognized in the field of medicine from the period as early 
as 30AD when Celsius first described the four basic markers of it: Rubor 
(redness), Calor (heat), Tumor (swelling) and Dolor (pain), to which Virchow in 1870 
added  the fifth element, Functio laesa (loss of function). The term inflammation  can  
be  defined  as  a  stereotypical  reaction  of  the  body  against  invading pathogens 
including viruses, bacteria, fungi, protozoa, cell injury or any toxic substance. 
Inflammation can be acute or short-lived which is rather non-specific and chronic or 
persistent where the process is more specific and is dominated by a specific cell 
type (e.g. neutrophils in chronic airway inflammation). 
 
1.2 Heme-Heme oxygenase System 
Heme oxygenase (HO) was first described by Tenhunen et al in 1968 as a distinct 
enzyme which degrades heme in hepatic microsomes. To date, HOs are the only 
known enzymes which are responsible for catalyzing the first and rate-limiting 
step of oxidative breakdown of heme into iron (Fe), carbon monoxide (CO) and 
biliverdin (Tenhunen et al. 1968).  Biliverdin is consecutively converted to bilirubin 
by the enzyme biliverdin reductase (Kapitulnik and Maines 2009). HO enzymatic 
activity requires three moles of molecular oxygen (O2) and NADPH. HOs are 
ubiquitously expressed in higher eukaryotes. Heme degrading systems similar to the 
HO system have also been described in lower entities such as bacteria, algae and 
flies (Ryter et al. 2006). 
 
The heme molecule is a double-edged sword, which on the one hand is required for 
the biological functions of many heme apoproteins such as hemoglobin, myoglobin 
and cytochrome c oxidase (Padmanaban et al. 1989; Wijayanti et al. 2004). On the 
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other hand free heme catalyzes the formation of reactive oxygen species (ROS) 
through Fenton chemistry and thus leads to oxidative-stress-induced tissue and 
cellular damage. Therefore, intracellular generation of heme is tightly regulated 
(Sassa 1996; Ponka 1999; Sassa 2004). Moreover, heme has recently been shown 
to have potent pro-inflammatory properties (Wagener et al. 2003; Soares et al. 
2009). Intravenous administration of heme has been shown to cause experimental 
inflammation with high leukocyte infiltration. Moreover, Jeney et al have shown that 
heme-dependent oxidation of low-density lipoproteins is involved in inflammation-
mediated tissue damage (Jeney et al. 2002). Hence, the HO system plays a crucial 
role in regulating the intracellular heme homeostasis. 
 
 
 
 
 
Fig 1: Heme is enzymatically degraded to yield carbon monoxide (CO), iron and 
biliverdin, which is converted into bilirubin in a coupled reaction (Vijayan et al. 2010). 
 
1.3 Heme oxygenase isoforms 
 
Two isoforms of HO have been characterized: HO-1, which is an inducible isoform of 
HO and HO-2, which is constitutively expressed. Both enzymes are genetically 
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distinct; the human HO-1 and HO-2 are localized on chromosomes 22q12 and 
16p13.3, respectively. Human HO-1 contains 288 amino acids and has a molecular 
weight of 32 kDa, whereas HO-2 consists of 316 amino acids with a total molecular 
weight of 36 kDa. Rat HO-1 and HO-2 share 43% amino acid homology and between 
species HO-1 in humans and rats have 80% similarity and HO-2 shares 88% 
similarity. The mouse HO-1 protein contains one cysteine while the other species do 
not. HO-1 and HO-2 also vary in their tissue expression pattern where HO-1 is found 
highly expressed in spleen and tissues that degrade senescent red blood cells, 
including specialized reticulo-endothelial cells of the liver and bone marrow (Maines 
et al. 1986; Ryter et al. 2006; Abraham and Kappas 2008). HO-2 in turn is highly 
expressed in the testes and brain (Trakshel et al. 1986). Both HO-1 and-2 contain a 
COOH-terminal hydrophobic domain, which allows attachment to membranes and 
has been predominantly found to be localised in the endoplasmic reticulum. Recent 
studies have, however, reported the localisation of HO-1 in the plasma membrane, 
mitochondria and nucleus (Kim et al. 2004; Converso et al. 2006; Sacca et al. 
2007). 
1.4 Heme oxygenase-1 
 
Why do we need two isoforms of an enzyme with the same property if its role is the 
same? In contrast to HO-2, HO-1 as aforementioned has an inducible gene 
expression. Strikingly, HO-1 gene expression can be induced not only by its 
substrate heme, but also by a wide variety of stress-inducing stimuli such as UV, 
heavy metals, quinones and LPS (Choi and Alam 1996; Immenschuh and Ramadori 
2000; Alam et al. 2004). The high inducibility of HO-1 gene expression raised the 
speculation that this enzyme might be involved in cytoprotection but experimental 
evidence was lacking. HO-1 was first linked to inflammation by Willis et al in an 
animal model of carragenin-induced pleurisy, in which specific upregulation of HO 
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enzyme activity attenuated a complement-dependent inflammation (Willis et al. 
1996). In 1997 the first report on a knockout mouse model of HO-1 (Poss and 
Tonegawa. 1997) marked a new era in the field of HO-1 with a rapid increase in 
interest for this protein leading to over 4000 publications. To date, only one case of 
human HO deficiency is reported in the literature (Yachie et al. 1999). Molecular 
alterations in both the patient and the knockout mouse with HO-1 deficiency will be 
discussed in the following chapters.  
1.5 HO-1 knockout mouse model studies 
Poss and Tonegawa (1997) analysed the iron reutilisation properties and observed 
an increased amount of oxidized proteins and lipid peroxidation levels in the HO-1 
knockout mouse with values of 51% and 95% in comparison to normal or 
heterozygous mice. HO-1 knockout mice showed signs of chronic inflammation with 
typical histological changes such as fibrosis, high peripheral leukocyte count and 
elevated infiltration of leukocytes into hepatic and renal tissue.  Moreover, cells from 
these knockout mice were highly sensitive to oxidative-stress induced by heme and 
H202. Furthermore, the production of ROS and other free radicals upon heme or H202 
stimulation was significantly higher in mouse embryonic fibroblasts (MEFs) of HO-1 
knockout animals in comparison to wild type cells. Moreover, both heterozygous as 
well as the wild type mice were more resistant to an endotoxin challenge as 
compared to knockout mice (Poss and Tonegawa 1997). Hence, HO-1 appeared to 
have an important function in protecting against LPS-induced toxicity. Similarly, 
when haemoglobin was administered, HO-1 knockout mice suffered from irreversible 
renal damage with a 100% mortality rate (Poss and Tonegawa 1997). It is 
noteworthy that HO-2 the constitutive isoform does not compensate for the loss of 
HO-1.  
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Furthermore, Kapturczak and colleagues (2004) explored the immune modulatory 
properties of HO-1 in HO-1 knockout mice and reported that the regulation of 
cytokine and chemokine expression was impaired in HO-1 knockout mice. High 
amounts of pro-inflammatory cytokines such as TNF-α, IL-6 and IL-1 were observed 
in these knock out animals. Although many in vitro studies have linked HO-1 with 
cytokine regulation this study was the first to show direct immunomodulatory 
functions of HO-1 (Kapturczak et al. 2004). Similarly, other studies have shown that 
adaptive immune responses are also impaired in these knockout mice (George et al. 
2008; Soares et al. 2009). In contrast, HO-2 knockout mice appear to have an intact 
immune regulation but exhibit defects in their central and autonomous nervous 
system (Burnett et al. 1998).  
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2: Wild type mice, heterozygous mice and HO-1 knockout mice 6-9 weeks old were 
challenged with endotoxin. HO-1 knockout mice exhibited high mortality rates (Toss and 
Ponegawa 1997). 
 
1.6 Human deficiency of HO-1 
Only one case of human deficiency of HO-1 has been reported so far (Yachie et al. 
1999). Nevertheless studies on this patient contribute to and validate most of the 
phenotype observed in the HO-1 knockout mouse model. The patient was a 6 
year old Japanese boy with growth retardation and delayed motor development. 
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From the time he was 2 years old he developed hepatomegaly and 
lymphadenopathy. His peripheral blood exhibited a high concentration of fragmented 
erythrocytes and showed increased levels of white blood cells with dysmorphic 
monocytes. One of the clinical features, which led to the diagnosis of a HO-1 gene 
defect, was the complete absence of the HO-1 enzyme in Kupffer cells in an 
immunohistochemical staining of hepatic biopsy specimens. Examination of lungs 
and heart revealed no significant abnormalities, whereas the deficiency of HO-1 led 
to a heavy damage of the kidney. E lectron microscopic analysis of the renal biopsy 
specimen revealed marked endothelial damage with an unknown deposition in renal 
glomerular capillary loops. Moreover, the endothelium was found to be detached 
widely. Infiltration of leukocytes, iron deposition and an increase in adhesion 
molecules such as ICAM, selectins and other inflammatory markers like von 
Willebrand factor were observed. Furthermore, absence of HO-1 rendered the 
lymphoblastoid cell line (LCL) (EBV transformed B cells) from the patient more 
sensitive to heme-induced oxidative stress.  In summary the absence of HO-1 led to 
an increased pro-inflammatory state in the patient (Yachie et al. 1999; Kawashima et 
al. 2002). 
 
 
 
 
Fig 3: High magnification of the kidney 
cortex in the human HO-1 deficient patient 
showing heavy infiltration of leukocytes 
(Yachie et al. 1999). 
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Fig 4: In comparison to the normal 
intraglomerular endothelium (bottom 
panel), the endothelium of the HO-1 
deficient patient (upper panel) was highly 
detached (arrow) and exhibited an unknown 
precipitate between the endothelium and 
the common basement membrane (Yachie 
et al. 1999) 
 
 
 
 
 
1.7 How does HO-1 regulate inflammation? 
 
The mechanism by which HO-1 confers its cytoprotective effects is widely 
discussed but still not clearly understood. A heavy body of literature suggests a 
pivotal role for CO and bilirubin, the two enzymatic by-products of HO-1 
reaction, in the cytoprotective effects. 
1.7.1 Biliverdin and Bilirubin (BR) 
Antioxidant properties of bilirubin have been described in the 1980s, before 
which it was considered only to be a toxic waste product excreted in bile. The 
antioxidant potential of bilirubin is comparable to the efficacy of alpha-
tocopherol, the most efficient antioxidant acting against lipid peroxidation 
(Kapitulnik 2004; Stocker 2004). Later, an anti-inflammatory function for 
bilirubin was shown in a microvessel model in which the leukocyte 
transmigration rate was observed to correlate with the amount of bilirubin 
produced from HO-1 activity (Hayashi et al. 1999). In a murine asthma model, 
it was shown that administration of bilirubin significantly reduced the VCAM-1-
dependent transmigration of leukocytes which is a mechanism also implicated in 
the pathogenesis of inflammatory bowel disease (Keshavan et al. 2005). In 
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another study on a rat model of endotoxemia it was noted that bilirubin 
treatment significantly blocked the hepatotoxicity seen after endotoxin 
exposure. Hepatic iNOS expression, serum levels of NO, TNF-α and 
aminotransferases, the profound markers of endotoxemia were significantly 
reduced (Wang et al. 2004). Similarly, another independent study reported 
analogous observations in a mouse model of endotoxemia, in which a single 
bolus addition of bilirubin rescued the mice from endotoxemia (Kadl et al. 
2007). Thus, the protective or anti-inflammatory functions of HO-1 can be in 
part attributed to bilirubin.  However, how exactly bilirubin brings about these 
anti-inflammatory effects remains an open question.  
1.7.2 Carbon monoxide 
The last decade has seen a rapid interest in understanding the physiological 
functions of CO. HO-1-generated CO has been implicated in a variety of 
physiological functions such as anti-apoptosis, neurotransmission, anti-
coagulation, vasodilation and most importantly protection against inflammation. 
The anti-inflammatory functions of CO have been reviewed in the following 
references (Ryter et al. 2002; Kim et al. 2006). An initial finding in this context 
was its ability to downregulate the inflammatory cytokines TNF-α, IL-1 beta, 
MIP-1 both in vitro in cell lines and in vivo in mice models challenged with 
LPS (Otterbe in et  a l.  2000) . Similar to bilirubin, CO also blocks the iNOS 
activity or production of NO but unlike the former does not regulate the protein 
expression of iNOS (Sawle et al. 2005). Abrogation of TNF-α, IL-6 and IL-1β 
production by CO is mediated by modulating the MAPKs of which p38 is 
required for most of its functions. More recently it was shown in a RAW 
264.7 murine macrophage cell line and in vivo in a mouse model for acute lung 
injury that CO via production of ROS induces the expression of PPAR-gamma 
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which is responsible for the downstream blockage of pro-inflammatory genes 
such as Egr-1 (Bilban et al. 2006). Apart from this, CO also induces the 
production of cGMP via activating the soluble guanyl cyclase (sGC). CO and 
bilirubin share similarities in their anti-inflammatory functions. Interestingly, CO 
and bilirubin appear to form an autocrine loop by which they induce the activity 
and expression of endogenous HO-1. The possibility that both CO and bilirubin 
exerts its anti-inflammatory function by inducing the endogenous HO-1 
enzymatic activity or a yet undefined function of HO-1 protein cannot be ruled 
out. 
1.7.3 HO-derived iron 
The third product of HO enzymatic reaction, iron is an important compound 
involved in redox-dependent enzyme reactions and bioenergetics. However, 
presence of free iron inside the cell may lead to the formation of toxic ROS, and 
therefore specific intracellular protective mechanisms exist to prevent 
intracellular toxicity. As an example, HO-1-derived iron bind to the intracellular 
iron storage protein ferritin and is transported outside the cell, thereby protecting 
the cell from oxidative damage (Ponka 1997). Interestingly, it has been shown in 
various models that upregulation of ferrittin correlated with the synthesis of HO-
1 (Balla et al. 1992; Ryter and Tyrrell 2000). Of note, deficiency of HO-1 in 
mice (Poss and Tonegawa 1997) and humans (Yachie et al. 1999; Kawashima 
et al. 2002) has been shown to be related with an increase iron deposition in 
the liver and kidney. 
1.8 How does HO-1 modulate an inflammatory response? 
Studies on the role of HO-1 in different cell types have revealed that HO-1 
exhibits cell-specific anti-inflammatory roles of which some are discussed in the 
following. 
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1.8.1 Role of HO-1 in endothelial cells 
Activation of endothelial cells is a crucial step in the process of inflammation 
because it regulates the influx of leukocyte population, especially that of 
polymorphonuclear neutrophils.  Pro-inflammatory  cytokines  modulate the 
gene expression of adhesion molecules such as E-selectin, P-selectin, ICAM-
1  and  VCAM-1  on  endothelial  cells,  thus  facilitating  the  adhesion  and 
transmigration of leukocytes into the site of injury (Muller 2003; Cook-Mills and 
Deem 2005; Immenschuh and Schroder 2006). In an in vivo rat model it was 
observed by intravital microscopy that induction of HO-1 in microvessel 
endothelial cells downregulates the adhesion of leukocytes to these cells during 
oxidative stress (Hayashi et al. 1999). In another study it was shown that 
inhibition of HO activity potentiated the heme-induced leukocyte infiltration into 
the tissues (Wagener et al. 2001). Recently, it was shown that the TNF-α-
mediated upregulat ion of  the adhesion molecules E-selectin and V-CAM1 
was downregulated by overexpressed HO-1 through inhibiting the activation of 
NF-B (Seldon et al. 2007). Thus, the major role for HO-1 in endothelial cells for 
counteracting inflammation seems to be achieved by regulating the expression 
of adhesion molecules on these cells and maintaining them in a less active 
state. Additionally, HO-1 also protects the endothelial cells from inflammatory 
damage by turning on an anti-apoptotic signaling cascade. This mechanism 
involves the degradation of the p38-alpha isoform of the p38 MAPK (Soares et 
al. 2002; Silva et al. 2006). 
 
 
1.8.2 Modulation of immunologically active cells by HO-1 
 
Among immunologically active cells, the most prominent model  of  study  for  
heme  oxygenase  functions  has  been  the  macrophages  or monocyte 
population. Studies in macrophages from HO-1 knockout mice suggested an 
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important functional role of HO-1 in these cells. HO-1 knock out cells produced 
high levels of the pro-inflammatory cytokines TNF-α, IL-6 and IL-1beta 
(Kapturczak et al. 2004).  Several independent  studies  have also reported  
the negative regulation of HO-1 on the proinflammatory genes 
cyclooxygenase 2 ( COX-2) and inducible nitric oxide ( iNOS) in macrophages, 
in which    induction  of  HO-1  has  been  shown  to  block  the production of 
prostaglandins as well as NO after LPS challenge (Lee et al. 2011; Park et al. 
2011). Similarly HO-1 has been shown to have an antioxidant  role in  
macrophages (Schulz-Geske et al. 2009).  
 
Another important function of HO-1 containing antigen presenting cells (APCs) 
seems to be the regulation of regulatory T-cells (Tregs). In a recent study it was 
shown that Treg cells require the presence of a functional HO-1 in the antigen 
presenting cells to execute their function of suppressing the effector T cell 
proliferation. Interestingly absence of HO-1 in Treg cells itself does not affect its 
suppressive activity in vitro (George et al. 2008) 
 
Dendritic cells (DCs) occupy the major population of antigen presenting cells 
and play an important role in adaptive immune responses by presenting the 
antigen to the B cells and T cells. A study on HO-1 functions in DCs revealed 
that immature human and rat DCs express HO-1 significantly which, upon 
receiving a maturation signal is downregulated. HO-1 if induced by co-treatment 
of a maturation signal which in this case was LPS with Cobalt protoporphyrin 
significantly blocked the expression of DC cell surface maturation markers such 
as MHC class II, CD86 and ICAM-1. Moreover their capacity to stimulate mixed 
lymphocyte reactions was abrogated. Hence, in DCs HO-1 seems to be one of 
the critical factors maintaining the balance between immature and mature DCs.  
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This function of HO-1 as proposed by the authors could be used to modulate 
functions of DCs in inflammatory disorders (Chauveau et al. 2005). 
1.9 Signaling mechanisms that regulate HO-1 
 
HO-1 is primarily regulated at the transcriptional level by multiple cis-acting 
regulatory elements (REs) present in the HO-1 gene promoter. The most 
studied of these REs are the two upstream enhancer regions termed E1 and E2 
(Alam 1994; Alam et al. 1994). E1 and E2 contain multiple copies of anti-
oxidant response elements (AREs) which have been shown to be involved in 
the specific upregulation of HO-1 in response to various stimuli (Nguyen et 
al. 2003). Interestingly, the human HO-1 gene contains a GT-microsatellite 
polymorphism in the proximal promoter region, which has been shown to be of 
major biological significance. Individuals carrying HO-1 gene allele with lower 
number of GT repeats have been associated with higher inducibility of HO-1 
gene and seem to be protected against various diseases such as cardiovascular 
disorders (Yamada et al. 2000). NF-E2 related factor 2 (Nrf2), AP-1 and NF-B 
are thought to be the key transcriptional factors involved in the regulation of 
HO-1 gene expression and the findings are briefly discussed below. 
1.9.1 Keap1/ Nrf2 system 
 
Nrf2 is a redox-dependent transcription factor which belongs to Cap’n’Collar 
(CNC) family of leucine-rich zipper proteins. Under basal conditions Nrf2 is 
bound to the cytoplasmic protein Kelch-like ECH-associated protein1 (Keap1) 
which mediates the proteosomal degradation of Nrf2. Under stress conditions, 
Keap1 is modified leading to the release of Nrf2, which translocates to the 
nucleus (Itoh et al. 1999; Kobayashi and Yamamoto 2005; Kimura et al. 2007; 
Kaspar et al. 2009). Once in the nucleus Nrf2 forms heterodimers with small 
maf proteins and binds to anti-oxidant response elements  in  the  promoter  of  
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various  phase II  detoxifying  enzymes,  such  as glutathione transferases and 
NADPH: oxidoreductase (Motohashi et al. 2002). 
 
A noteworthy feature of Nrf2 signaling with respect to the specific up-
regulation of HO-1 gene is the interplay between Nrf2 and the transcriptional 
repressor Bach1. Under basal conditions Bach1 is bound to ARE-elements on 
HO-1 promoter. But when stimulated with heme, Bach1 dissociates from HO-1 
promoter and is rapidly transported to the cytoplasm allowing the incoming Nrf2 
to bind to the Bach1-free anti-oxidant response element and thus activate the 
transcription of HO-1 gene (Ogawa et al. 2001). Similar mechanisms have been 
reported for other stimuli, such as sodium arsenite (Reichard et al. 2008). 
 
 
 
(Paine et al. 2010) 
 
Fig 4: Regulatory interplay between the transcription factors Nrf2 and Bach1 on the gene 
expression of HO-1. Under normal conditions Bach1 acts as a repressor of the HO-1 gene 
by binding to the AREs of the HO-1 promoter. When cellular heme levels are high Bach1 
dissociates from the promoter and translocate to the cytoplasm. At the same time Nrf2 
translocate to the nucleus and bind to AREs and activate the transcription of HO-1 gene 
(Paine et al. 2010) 
 
Normal conditions Prooxidant conditions 
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1.9.2 NF-B 
 
The NF-B/Rel family of transcription factors consist of many proteins factors 
which form homodimers and heterodimers among themselves to drive the gene 
expression of a plethora of pro-inflammatory genes such as cytokines, 
adhesion molecules and anti-oxidant proteins (Gilmore 2006; Perkins and 
Gilmore 2006). The classical activation pathway of NF-B has been studied 
extensively. Under basal conditions NF-B is maintained in the cytoplasm by 
the NF-B inhibitor protein, IB.  Upon  receiving  an  activation  signal  IB  is  
phosphorylated  and undergoes  degradation  whereby  NF-B  is  released.  
NF-B translocates to the nucleus where it binds to the NF-B binding elements 
on the gene promoter and induces the gene expression (Ghosh and Hayden 
2008). 
 
The role for NF-B in regulating HO-1 gene expression has been discussed 
controversially. Although NF-B inhibitors have been shown to block HO-1 
induction by various stimuli  such  as  LPS,  only  two  studies  have  so  far  
reported  the  presence  of functional NF-B binding elements in the HO-1 
promoter. In one study it was shown that TPA-induction of HO-1 is regulated 
by a proximal NF-B site in the rat HO-1 promoter. Another independent study 
reported that nitric oxide synthase upregulates HO-1 via a NF-B-dependent 
pathway and is regulated by a NF-B element in the mouse HO-1 promoter 
(Naidu et al. 2008; Li et al. 2009). 
 
1.9.3 AP-1 
 
Alam and colleagues have reported that the transcription factor AP-1 is 
important for the induction of mouse HO-1 (Alam and Den 1992; Alam et al. 
1995). AP-1 belongs to a family of transcription factors which is involved in 
various cellular processes including stress responses (Karin 1995; Hess et al. 
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2004). Elucidating the role of AP-1 in HO-1 gene expression is highly complex 
due to the fact that the AP-1 binding site (TGATGCA) is a part of the HO-1 
ARE sequence (TGCTGAGTCA). Most likely there is a cross-talk between Nrf2 
and AP-1 family of transcription factors and this notion has been supported by 
the recent finding that c-jun in association with Nrf2 induce the expression of 
the ARE-regulated genes NADPH:quinone oxido reductase and glutamate-
cysteine ligase (Alam et al. 1999; Levy et al. 2009). 
 
In summary, multiple transcription factors may act co-ordinately to upregulate 
HO-1 gene expression during stress conditions. 
1.10 Role of kinases in HO-1 signaling 
Generally, transcription factors are regulated by intracellular signaling cascades, 
which are controlled by the activation of various kinase and phosphatase 
modules and the redox state of the cell. Due to space limitations in this thesis 
the role of these kinases are not described in detail. Hence, only the mitogen 
activated protein kinases (MAPK), which have been explored in my work, 
specifically the role of p38 MAPK for the regulation of HO-1 gene expression are 
highlighted. 
1.10.1 The MAPK pathway 
Activation of MAPKs has been shown to play a central role in the regulation of 
HO-1 gene expression (Alam and Cook 2007). There are three major 
subfamilies of MAPKs: p38 MAPK, extracellular signal-regulated kinase (ERK) 
and c-Jun N-terminal kinase (JNK) (Kyriakis and Avruch 2001). ERK is shown 
to be mainly involved in the activation of signaling pathways induced by growth 
factors and hormones, whereas JNK and p38 MAPK are considered to be 
activated under stress conditions (Kyriakis and Avruch 2001; Wagner and 
Nebreda 2009). 
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Activation of p38 MAPK has been shown to be assoc iated with  antioxidant 
and anti-inflammatory responses. Several studies indicate that blocking the 
activity of p38 MAPK either by chemical inhibitors or by gene silencing blocks 
the protein induction of HO-1 in response to various stress-stimuli (Cook-Mills 
and Deem 2005; Alam and Cook 2007). It is noteworthy that the different 
isoforms of p38 MAPK have opposing roles in the regulation of HO-1, which 
has been demonstrated for sodium arsenite and LPS induced expression of HO-
1 (Kietzmann et al. 2003; Wijayanti et al. 2004). 
 
Apart from MAPKs other kinases such as JAK kinase (Zhang et al. 2006) and 
PI3 kinase (Martin et al. 2004) also have a role in the regulation of HO-1. It is 
important to note that the regulation of HO-1 by kinases is stimuli-specific and 
in some cases cell-type specific (Paine et al. 2010). 
 
(Paine et al. 2010) 
Fig 5: Signaling cascades that lead to the activation of Nrf2 regulating HO-1 gene 
expression (Paine et al. 2010). 
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1.11 LPS signaling of HO-1 
 
LPS, a cell wall component of gram negative bacteria is a potent inducer of 
inflammation and has been extensively used to induce and study sepsis 
in mouse models. LPS signaling in cells is mediated by the CD14 receptor 
in association with the TLR4 receptor present on the cell surface. TLR4 
activation is followed  by  activation  of  a  series  of  adaptor  molecules  
that  lead to the phosphorylation and degradation of IB and subsequently 
to the release of the transcription factor NF-B (Zhu and Mohan 2010). LPS 
has been previously shown to induce the expression of HO-1 in various 
cell types. Camhi and co-workers (1995) described that LPS-induced HO-1 
upregulation in murine macrophages is primarily mediated by the 
transcription factor AP-1 (Camhi et al. 1995). Independently, others have 
demonstrated tha t  the transcription factor Ets2 is crucial for the 
promoter regulation of mouse HO-1 (Chung et al. 2005). Previous studies 
from the Immenschuh laboratory have indicated a role for NO, NF-B and 
p38 MAPK in the LPS-induced upregulation of HO-1 in macrophages 
(Immenschuh et al. 1999; Wijayanti et al. 2004). The signaling 
mechanisms that lead to the induction of HO-1 are regulated by multiple 
factors and are highly complex. 
 Noteworthy, increased HO-1 activity has been shown to exert inhibitory 
effects on the intracellular signaling initiated by TLR4 activation (Nakahira 
et al. 2006). This regulatory interplay between TLR4 and HO-1 seems to 
form a negative feedback loop, in which HO-1 activation controls the 
excessive activation of macrophages by LPS. This feedback circuit might be 
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of major significance for the regulation of inflammatory responses.  
Understanding this complex mechanism in detail will help us develop new 
therapeutical strategies to treat inflammatory conditions such as sepsis. 
1.12 Bruton’s Tyrosine kinase 
 
Bruton’s tyrosine  kinase  (Btk)  is  a member  of  the Tec  family  of  
non-receptor tyrosine kinases and is found to be expressed in all cells 
of the hematopoietic lineage except for plasma cells and T cells. The 
defining feature of this kinase is the presence of a pleckstrin homology 
(PH) domain at the N-terminus. Naturally occurring mutations on this 
kinase, that make it non-functional were identified initially in humans in a 
rare genetic disorder called X-linked agammaglobulinemia (XLA) (Vetrie et 
al. 1993), which is characterized by a deficiency of mature circulating B-
cells and immunoglobulins. In murine models, a single point mutation 
(R28C) in the mouse Btk gene or targeted disruption of the Btk gene is 
associated with a similar phenotype and is termed XID syndrome (Rawlings 
et al. 1993; Khan et al. 1995). 
 
In addition to the PH domain Btk also contains three Src homology domains 
(SH1, SH2 and SH3) and the Tec homology domain (TH) that is conserved 
in all the members of the Tec family except for Etk/Bmx. Btk is versatile in 
its interaction with other proteins. Moreover, the presence of these 
domains makes it possible for Btk to form protein-protein as well as 
protein-lipid interactions. Under basal conditions, the SH3 domain and the 
TH domain form an intramolecular interaction which folds Btk in a “closed” 
inactivated form. Upon receiving an activation signal, the protein undergoes 
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a conformational change and is then translocated to the membrane via its 
PH domain (Mano 1999). 
 
Initial studies mainly focused on the role of this kinase in B cells which 
indicated that Btk is crucial for their function and development 
(Satterthwaite and Witte 2000). Recently, it has been shown that Btk 
plays a major role in TLR-induced innate immune responses evoked in 
macrophages (Jefferies and O'Neill. 2004). Specifically, inhibition of Btk in 
macrophages caused an impaired TLR4-induced gene expression of central 
pro- and anti-inflammatory cytokines such as TNF-, IL-1 and IL-10 
(Horwood et al. 2003; Doyle et al. 2005; Horwood et al. 2006; Koprulu and 
Ellmeier 2009). Moreover, Btk is required for appropriate phagocytic 
function and for the survival of mononuclear phagocytes (Schmidt et al. 
2006; Jongstra-Bilen et al. 2008).  
1.12.1 Regulation of HO-1 gene expression in mononuclear 
phagocytes 
Mononuclear phagocytes (monocytes, macrophages) are immune cells which 
play an important role in modulating an inflammatory response. On the one 
hand they play a crucial role in the initiation of an inflammatory response via 
secretion of pro-inflammatory cytokines, such as IL-1, IL-6 and TNF-α and by 
the intracellular generation of ROS, which aids in killing the phagocytosed 
pathogen. On the other hand mononuclear phagocytes promote resolution of 
inflammation by phagocytosing apoptotic cells and by the secretion of the 
anti-inflammatory cytokines IL-10 and TGF-β. Recent evidence suggests that 
the immunomodulatory functions of HO-1 in mononuclear phagocytes may be 
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involved in the regulation of an inflammatory immune response. The 
prototypical inflammatory stimulus LPS, which initiates signaling by binding 
to TLR4, has been shown to induce HO-1 in macrophages.  
1.13 Aims of the study 
1.13.1 Part A 
TLR-induced signaling mechanisms activate diverse signaling molecules. 
Recently it was shown that Btk, a kinase which is crucial for the development 
and effector functions of B-cells, is involved in the TLR-induced signaling of 
cytokines. Signaling pathways are highly complex and many signaling 
molecules that have been shown to be involved in cytokine regulation have 
also been implicated in the regulation of HO-1 gene.  In the first part of this 
thesis, therefore it should be analyzed whether Btk would also be involved in 
the TLR-induced regulation of the HO-1 gene. Furthermore, downstream 
signaling events to the HO-1 promoter should be analyzed and the role of 
ROS and Nrf2 should be evaluated in this regulatory process.  
1.13.2 Part B 
In the second part of this thesis the role of p38 MAPK in the regulation of 
HO-1 should be analyzed. Activation of p38 MAPK has been shown to be 
crucial for the induction of HO-1 gene expression in response to various 
stimuli including LPS. Furthermore, our group noticed an opposing effect of 
p38 MAPK on HO-1 gene expression during conditions when under the 
absence of an external stimulus, chemical inhibitors of p38 MAPK were used. 
Therefore, in this thesis it should be analyzed which functional role p38 MAPK 
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exerts on the regulation of the HO-1 gene. Moreover, the role of p38 MAPK in 
the presence and absence of external stimuli should be compared and the 
downstream signaling pathways explored. Finally, the cross-talk between p38 
MAPK and the other MAPKs such as JNK and ERK should be evaluated. 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Experimental animals 
Specific pathogen free (SPF) C57Bl/6J mice 8-12 weeks old were purchased 
for experimental purposes from Charles River Laboratories (Sulzfeld, 
Germany). Btk knockout mice and their wildtype littermates were a generous 
gift from Dr. Cornelia Brunner (Dept. of Biochemistry, Ulm University Medical 
School). They had free access to food and water and were kept under 
standardized environmental conditions (12h light/dark cycle, 23°C ± 1°C and 
55% ± 1% relative humidity).     
2.1.2 Laboratory instruments 
Table 1. All laboratory instruments used for experiments in this thesis are listed with notice of 
corresponding suppliers: 
Instruments Company name 
AGFA Horizon Ultra Colour Scanner  AGFA, Mortsel, Belgium 
Biocell A10 water system Milli Q-Millipore, Schwalbach, Germany 
Biofuge Fresco Heraeus, Hanau, Germany 
Biofuge Pico Heraeus, Hanau, Germany 
Bio-Rad electrophoresis apparatus Bio-Rad, Heidelberg, Germany 
Dish washing machine  Miele, Gütersloh, Germany 
Cary 50 Bio-UV-visible spectrophotometer Varian, Darmstadt, Germany 
Gel-Doc 2000 gel documentation system Bio-Rad, Heidelberg, Germany 
Hera cell 240 incubator Heraeus, Hanau, Germany 
Hera safe, clean bench Heraeus, Hanau, Germany 
Ice machine, Scotsman AF-100 Scotsman Ice Systems, Vernon Hills, IL, USA 
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Leica DMRD fluorescence microscope Leica, Bensheim, Germany 
Leica DC 480 camera   Leica, Bensheim, Germany 
Microwave oven LG, Willich, Germany 
Mini-Protean 3 cell gel chamber Bio-Rad, Heidelberg, Germany 
Multifuge 3 SR centrifuge Heraeus, Hanau, Germany 
pH meter IKA, Weilheim, Germany 
Pipettes 2.5 µl, 10 µl, 20 µl, 100 µl, 200 µl and 
1000 µl. 
Eppendorf, Hamburg, Germany 
Power supply - 200, 300 and 3000 Xi Bio-Rad, Heidelberg, Germany 
Pressure/Vacuum Autoclave FVA/3 Fedegari, Albuzzano, Italy 
Pump Drive PD 5001 Heidolph Instruments, Schwabach, Germany 
Sorvall Evolution RC centrifuge Kendro, NC, USA  
SmartspecTM 3000 spectrophotometer Bio-Rad, Heidelberg, Germany 
Thermo plate Medax, Kiel, Germany 
Trans-Blot SD semidry transfer cell Bio-Rad, Heidelberg, Germany 
Trimmer TM60 Reichert, Wolfratshausen, Germany 
TRIO-thermoblock  Biometra, Göttingen, Germany 
Ultra balance LA120 S Sartorius, Göttingen, Germany 
Vortex M10 VWR International, Darmstadt, Germany 
Water bath shaker GFL 1083  GFL, Burgwedel, Germany 
 
2.1.3 General materials and culture media 
Table 2. General materials and culture media used in this thesis are listed with notice of corresponding 
suppliers: 
General materials and culture media Company name 
BioMax MR-films Kodak, Stuttgart, Germany 
Cover slips 12mm diameter Menzel-Gläser, Braunschweig, Germany 
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Culture dish (35mmx10mm) BD Biosciences, Heidelberg, Germany 
Culture dish (100mmx20mm) BD Biosciences, Heidelberg, Germany 
Filter tips and canules Braun, Melsungen, Germany 
Dulbecco’s modified Eagle’s medium (DMEM) PAA, Pasching, Austria 
Molecular weight markers (DNA, RNA) Fermentas, St.Leon-Rot, Germany 
RPMI medium PAA, Pasching, Austria 
Multi-well cell culture plates (12 wells) BD Biosciences, Heidelberg, Germany 
Oligo(dT)12-18 primer Invitrogen, Heidelberg, Germany 
PVDF membranes Millipore, Schwalbach, Germany 
qRT-PCR primers (see table 14) Operon, Cologne, Germany  
 
2.1.4 Proteins and enzymes  
Table 3. Proteins and enzymes used in this thesis here are listed with notice of corresponding suppliers: 
Proteins and enzymes Company name 
Bovine serum albumin (BSA) Roth, Karlsruhe, Germany 
Fetal calf serum (FCS Gold Heat Inactivated) PAA, Pasching, Austria 
Immunostar-alkaline phosphatase Bio-Rad, Heidelberg, Germany 
Milk powder Roth, Karlsruhe, Germany 
Precision Plus protein standards, dual color  Bio-Rad, Heidelberg, Germany     
Precision Plus protein standards, unstained Bio-Rad, Heidelberg, Germany 
Primary antibodies (see table 15) Various companies see table 15 
Secondary antibodies (see table 16) Various companies see table 16 
SuperScript II reverse transcriptase Invitrogen, Karlsruhe, Germany 
Taq DNA polymerase  Eppendorf, Hamburg, Germany 
Accutase PAA, Pasching, Austria 
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2.1.5 Chemicals 
Table 4. List of chemicals and drugs used in this study with notice of corresponding suppliers: 
Chemicals  Company name 
Acrylamide Roth, Karlsruhe, Germany 
Agarose LE Roche, Grenzach-Wyhlen, Germany 
Ampicillin Difco, Detroit, MI, USA 
Bradford reagent Sigma, Steinheim, Germany 
Bromophenol blue Riedel-de-Haën, Seelze, Germany 
Cell culture lysis reagent 5X (CCLR) Promega, Madison, WI, USA 
Dimethylsulfoxide (DMSO) Sigma, Steinheim, Germany 
Ethanol Riedel-de-Haën, Seelze, Germany 
Ethidium bromide Fluka, Neu-Ulm, Germany 
Ethylene diamine tetraacetic acid (EDTA) Fluka, Neu-Ulm, Germany 
Glycine Roth, Karlsruhe, Germany 
Glycerol Sigma, Steinheim, Germany 
β-Glycerolphosphate Sigma, Steinheim, Germany 
H2-dichlorofuorescein-diacetate (H2-DCFDA) Invitrogen, Karlsruhe, Germany 
Luciferase assay systems Promega, Madison, WI, USA 
Mowiol 4-88 Polysciences, Eppelheim, Germany 
N-Propyl-gallate Sigma, Steinheim, Germany 
Paraformaldehyde (PFA) Sigma, Steinheim, Germany 
Penicillin/Streptomycin  PAN Biotech, Aidenbach, Germany 
Phenylmethanesulfonyl fluoride (PMSF) Serva, Heidelberg, Germany 
Ponceau S Serva, Heidelberg, Germany 
Rotiphorese Gel 30 Roth, Karlsruhe, Germany 
RNaseZap Sigma, Steinheim, Germany 
Sodium carbonate Merck, Darmstadt, Germany 
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Sodium chloride Roth, Karlsruhe, Germany 
Sodium hydrogen carbonate Merck, Darmstadt, Germany 
Sodium hydroxide Merck, Darmstadt, Germany 
Sucrose Merck, Darmstadt, Germany 
Sodium dodecyl sulphate (SDS) Sigma, Steinheim, Germany 
Tetramethylethylenediamine (TEMED) Roth, Karlsruhe, Germany 
TransIT-LT1 transfection reagent Mirus Bio LLC 
Trishydroxymethylaminomethane (Tris) Merck, Darmstadt, Germany 
Triton X-100 Sigma, Steinheim, Germany 
Trypan blue Sigma, Steinheim, Germany 
Tween 20 Fluka, Steinheim, Germany 
All other standard reagents if not indicated were purchased from Sigma. 
2.1.6 Kits 
Table 5. List of kits used in this study with notice of corresponding suppliers: 
Kits Company name 
Dual luciferase kit Promega, Madison, WI, USA 
Nitrite detection kit Promega, Madison, WI, USA 
PCR kit Qiagen, Hilden, Germany 
QIAGEN Plasmid midi kits Qiagen, Hilden, Germany 
RNeasy kit Qiagen, Hilden, Germany 
RT-PCR kit Invitrogen, Karlsruhe, Germany 
2.1.7 Inhibitors and Ligands 
Table 6. List of used kits in this study with notice of corresponding suppliers: 
Ligands, Inhibitors Company name 
Flagellin (TLR5 ligand) Qiagen, Hilden, Germany 
LFM-A13 (Btk inhibitor) Calbiochem, La Jolla, CA, USA 
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Lipotechoic acid (TLR2 ligand) Invivogen, San Diego, CA, USA 
LPS (B14: E.coli) Invivogen, San Diego, CA, USA 
LPS (pure) (TLR4 ligand) Invivogen, San Diego, CA, USA 
N-acetylcysteine (ROS scavenger) Roth, Karlstuhe, Germany 
ODN2395 (TLR9  ligand) Invivogen, San Diego, CA, USA 
PD98059 (ERK MAPK inhibitor) Calbiochem, La Jolla, CA, USA 
PMA (PKC activator) Invitrogen, Karlsruhe, Germany 
Poly I:C (TLR3 ligand) Invivogen, San Diego, CA, USA 
R837 (TLR7 ligand) Invivogen, San Diego, CA, USA 
SB202190 (p38 MAPK inhibitor) Calbiochem, La Jolla, CA, USA 
SB203580 (p38 MAPK inhibitor) Calbiochem, La Jolla, CA, USA 
SP600125 (JNK MAPK inhibitor) Calbiochem, La Jolla, CA, USA 
 
2.1.8 Bacterial strains, cell lines and plasmid constructs 
Table 7. List of cell lines and bacterial strains used in this study with notice of corresponding suppliers: 
E.coli strains and cell lines 
 
Company name 
Nrf2 MEF mouse embryonic fibroblasts Dr. Larry Higgins (University of Dundee, UK) 
p38 MEF mouse embryonic fibroblasts Dr. Angel R. Nebreda (Spanish National Cancer 
Center, Madrid, Spain) 
RapidTransTM competent E.coli Active Motive, Rixensart, Belgium 
RAW 264.7 mouse macrophage cell line ATCC, Manassas, VA, USA 
 
Table 8. List of plasmids used in this study with notice of corresponding suppliers: 
Plasmids 
 
Company name 
BtkDNK430R, BtkDNR28C Dr. Sarah Doyle (Trinity College, Dublin, 
Ireland) 
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pAP-1-luc Dr. Craig A. Hauser (The Burnham Institute, La 
Jolla, CA) 
pARE-luc Dr. William E. Fahl (University of Wisconsin, 
Madison, WI, USA) 
pcDNA3.1 Stratagene, La Jolla, CA, USA 
pE2-luc Dr. Jawed Alam (Alton Ochsner Medical Center, 
New Orleans, LS) 
pGL3 basic, pGL2 basic Promega, Madison, WI, USA 
pHO-4045-luc Dr. Mark A. Perrella (Harvard Medical School, 
Boston, MS, USA) 
pTNF-585-luc Dr. Gordon Duff (University of Sheffield, 
Sheffield, UK) 
Gal4 plasmid system (pFR-luc, pFA-CHOP, 
pFC2-dbd) PathDetect CHOP trans-Reporting 
system) 
Stratagene, La Jolla, CA, USA 
 
2.1.9 Buffers and solutions 
Table 9. Solutions for immunofluorescence: 
Fixative solution  4% PFA in 1X PBS (150mM NaCl, 13.1mM K2HPO4 , 5mM KH2PO4 ), 
pH 7.4 
Glycine (1%) 1g Glycine in 100 ml of 1X PBS buffer 
Glycine (1%) + Trition X-
100 (0.3%) 
1g Glycine in 100 ml of 1X PBS buffer + 0.3 ml Triton X-100 
Blocking buffer- 1% PBSA 
+ 0,05% Tween 20 
To 2g BSA add 200 ml of 1X PBS and 100 µl of Tween 20 
Mowiol 4-88 solution Overnight stirring of 16.7 % Mowiol 4-88 (w/v) + 80 ml of 1X PBS, 
add 40 ml of glycerol, stir again overnight; centrifuge at 15,000 g for 
1h and take off the supernatant and store at -20°C 
Anti-fading agent (2.5%)  2.5g N-propyl-gallate in 50 ml of PBS and add 50 ml of glycerol 
Mounting medium 3 parts of Mowiol 4-88 + 1 part of anti-fading agent 
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Table 10. Solutions for isolation of proteins for SDS PAGE and Western blotting: 
Cell lysis buffer (1X) 50mM Tris +150mM Nacl +1% Triton-X-100 (pH 7.4). Before use 
10% protease inhibitor cocktail was added 
Resolving gel buffer A 1.5M Tris-HCl, pH 8.8 + 0.4% SDS  
Stacking gel buffer B 0.5M Tris-HCl, pH 6.8 + 0.4% SDS  
Resolving gel (12%) 
(for 4 SDS-PAGE gels)  
8 ml of 30% acrylamide + 10 ml of buffer A + 2 ml of ddH2O + 15 µl 
of TEMED + 130 µl of 10% APS 
Stacking gel 
(for 4 SDS-PAGE gels) 
1.25 ml of 30% acrylamide + 5 ml of buffer B + 5 ml of DH2O + 15 µl 
of TEMED + 130 µl of 10% APS 
10X Sample buffer 3.55 ml ddH2O + 1.25 ml 0.5M Tris-HCl, pH 6.8 + 2.5 ml 50% (w/v) 
glycerol + 2.0 ml 10% (w/v) SDS + 0.05% bromophenol blue. Before 
use, add 50 ml β-mercaptoethanol 
10X Electrophoresis buffer 250mM Tris + 2M glycin + 1% SDS  
20X Transfer buffer Bis-Tris-HCl buffered (pH 6.4) for transfer of proteins from 
polyacrylamide gel to PVDF membrane; NuPAGE transfer buffer, 
Invitrogen, Heidelberg, Germany 
10X TBS 0.1M Tris + 0.15M NaCl in 1000 ml of ddH2O, adjust to pH 8.0 
10% Blocking buffer 10g fat free milk powder in 100 ml of ddH2O 
5% BSA 5g BSA in 100 ml 1X TBST +0.05% Tween 20, pH 8.0 
1X Washing buffer (TBST) 10mM Tris/HCl, 0.15M NaCl, 0.05% Tween 20,  pH 8.0 
Ponceau S solution 0.1% (w/v) Ponceau S in 5% (v/v) acetic acid 
 
Table 11.  Solutions for molecular biology: 
Transfer buffer 10X (TAE) 40mM Tris base + 20mM acetic acid + 1mM EDTA, pH 7.6 
RNA-loading dye (10 ml) 16 µl saturated aqueous bromophenol blue, 80 µl 500mM EDTA 
(pH8.0), 720 µl 37% formaldehyde, 4 ml 10X gel buffer, then fill up 
to 10 ml with ddH20 
10X RNA transfer buffer 200mM MOPS, 50mM  sodium acetate, 10mM EDTA, pH 7.0 
1X Formaldehyde gel  100 ml 10X RNA transfer buffer + 20 ml 37% formaldehyde + 880 ml 
ddH20 
LB medium 0.17 M sodium chloride + 1% Trypton + 0.5% Yeast extract, pH 7.0 
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LB-Agar LB medium + 1 g/50 ml Agar + 100 µg/ml Ampicillin 
Plasmid mini-prep-
Solution 1 
50mM glucose + 25mM Tris-Cl (pH-8.0)+ 10mM EDTA + fresh 0.33 
µg/µl RNAse A 
Plasmid mini-prep-
Solution 2 
1% SDS in 0.2 N NaOH 
Plasmid mini-prep-
Solution 3 
3M potassium acetate + 11.5% glacial acetic acid 
6X-Agarose loading dye 0.025% (w/v) bromophenol blue without xylene cyanol + 30% (v/v) 
glycerol 
 
2.1.10 Primers 
The inventoried realtime rtPCR primers were ordered from Applied Biosystems. 
The catalogue numbers and the company provided names of the primers used 
are mentioned in the Table below. 
Table 12.  List of Primers used in this study 
Gene symbols Catalogue number Company provided primer name 
Gene of Interest  
Cycloxygenase 2 (COX-2) Cat. # 4331182 Mm03294838_g1 
Heme oxygenase-1 (HO-1) Cat. # 4331182 Mm00516005_m1 
NADPH quinone oxidoreductase 
1 (NQO1) 
Cat. # 4331182 Mm01253561_m1 
Loading control  
Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) 
Cat. # 4331182 Mm99999915_g1 
28s ribosomal rna (28SrRNA) Cat. # 4331182 Mm03682676_s1 
2.1.11 Antibodies 
Table 13 and 14 depict the list of primary and secondary antibodies, which were 
used for immunofluorescence and for Western blots.  
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2.2 Methods 
2.2.1 Cell culture 
RAW264.7 cells, MEF from p38α-/- mice and MEF from Nrf2-/- mice were grown in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal calf 
serum, 100 U/ml penicillin and 100 µg/ml streptomycin. All cell cultures were 
kept under air/CO2 (19:1) at 100% humidity. 
2.2.2 Transformation and preparation of plasmid DNA 
The reaction tube containing the competent E.coli cells were removed from -80o 
C storage and placed on ice to thaw. 1 µg of the plasmid DNA was mixed with 
the thawed cells by gently tapping the tube and was incubated on ice 
immediately for 30 min. The cells in the transformation reaction tube were 
subjected to a heatshock at 42 oC in a waterbath for exactly 30 s and the tube 
was placed thereafter quickly on ice for 2 min. 250 µl of LB medium were added 
to the tube and the cells were incubated at 37 oC for 1 h with shaking at 225-
250rpm. Using a sterile spreader, 20-200 µl of transformation mixture was 
plated out on a pre-warmed LB agar plate. Plates were inverted and incubated 
overnight at 37 oC. 
2.2.3 Mini and midi preparation of plasmid DNA 
A single bacterial colony was inoculated into 3 ml of selective LB medium and 
was grown for 12 h with vigorous shaking. 700 µl of culture bacteria were mixed 
with 300 µl of 50% glycerol and stored at -80oC as frozen stock. The plasmid 
preparation was done with a modified alkaline lysis protocol of Qiagen (Qiagen 
Miniprep plasmid kit). Shortly, 1 ml of the bacterial suspension was centrifuged 
at 13,000 rpm for 30 s. The pellet was resuspended in 150 µl of solution 1 and 
incubated at room temperature (RT) for 5 min after which 150 µl of solution 2 
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was added to the mixture and incubated further for 5 min. To this mixture 150 µl 
of solution 3 was added, incubated for 5 min at RT and then centrifuged for 5 
min. 1 ml cold ethanol (100%) was added to the supernatant, vortexed and 
incubated for 10 min at RT and centrifuged for 10 min. The pellet was washed 
with 1 ml ethanol (70%) and centrifuged at maximum speed for 2 min. The 
pellet obtained was air-dried. 20-30 µl of 10mM Tris-Cl (pH-8.0) was added to 
the pellet and incubated for 2 min at RT. 
For amplification of plasmids, plasmid preparations were performed with Qiagen 
plasmid Midi or Maxi kits according to the manufacturer’s instructions. The 
concentration of plasmid DNA was calculated by measuring the absorbance at 
260 nm and 280 nm. 
Agarose gels (1-2%) were used for analyzing the isolated plasmid DNA. Briefly, 
the agarose (10 mg/ml) was melted in 1X TAE buffer using a microwave oven at 
500W. Ethidium bromide was added to the solution at a dilution of 1:10,000 and 
then poured into a casting platform and the gel was allowed to set. DNA samples 
were mixed with 5 µl of 6x loading buffer before loading into the wells. The 
voltage of electrophoresis was set to 10 V/cm. The intercalated ethidium 
bromide in the DNA was visualized by placing the gel on a UV light source. 
2.2.4 Transfection and luciferase assay 
Cells were seeded in 6-well plates 24 h prior to transfection at a density of 5x105 
cells/well. The lipofection solution was prepared by adding 2 µl of Trans IT® LT-1 
transfection reagent to 110 µl of DMEM serum free medium (per well) and 
incubated for 15min at RT. To this mixture 1 µg of the reporter plasmid was 
added mixed gently and further incubated for another 15min at RT. The medium 
in the wells were replaced by adding fresh medium (2ml/well). 100 µl of the 
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DNA-lipid complex was added drop by drop to each well containing cells in the 
presence of medium with 10% FBS. The plates were swirled gently to ensure 
even dispersal of the complex and the plates were cultured for 24 h before cell 
harvest or treated with various stimuli as indicated. 
For co-transfection experiments 1 µg of expression vector plasmid was added 
together along with the reporter plasmid. For these experiments the amount of 
Trans IT transfection reagent used per well was increased to 4 µl. 
2.2.4.1 Luciferase activity assay 
2.2.4.1.1 Preparation of cell lysates 
1 volume of the luciferase cell culture lysis reagent (CCLR) (5X) was mixed with 
4 volumes of sterile water to prepare the working concentration 1X. The growth 
medium from the transfected culture cells was removed carefully and rinsed with 
1X PBS. 100-200 µl of 1X CCLR reagent was added to each well and the plate 
was shaked several times to ensure complete coverage of cells with lysis buffer. 
Cells were scrapped from the culture dishes and transferred to an eppendorf 
tube. The tube was placed on ice vortexes for a short period of 15 s and then 
centrifuged at 13,000 g for 30 s at RT. The cell lists were used for the luciferase 
assay directly. 
2.2.4.1.2 Luciferase assay 
Prepared luciferase assay reagent was mixed well and equilibrated at RT before 
use. The illuminometer was first primed with luciferase assay reagent. The 
illuminometer was programmed to perform a 2s measurement delay followed by 
a 10s measurement read for luciferase enzyme activity. 50 µl of the sample was 
dispensed into illuminometer tubes. The reading time was adjusted to work in a 
linear range in the respective experiment. Relative light units of luciferase 
activity were normalised to mg protein values of the samples. 
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2.2.5 Isolation and culture of primary alveolar macrophages 
Alveolar macrophages were isolated as previously described (Zhang et al. 2008). 
Briefly, after cervical dislocation of the mice, skin of the cervical region was cut 
open and the trachea exposed surgically. A canula was inserted into the trachea 
and with a 1 ml syringe, 0.5 ml of prewarmed DPBS saline containing 0.5mM 
EDTA were instillated into the trachea, withdrawn and the lavage was collected 
in a 5 ml conical centrifuge tube. The instillation and lavage steps were repeated 
10 times and the collected lavages thereafter centrifuged for 10 min at 400g. 
The cells were counted and 1x105 cells were plated in each well of a 24 well 
plates containing coverslips. After 4 h the medium was removed to get pure 
macrophage cultures and replaced with fresh medium. 
 
 
 
 
 
 
 
 
 
Fig6. Primary alveolar macrophages were labelled with the macrophage marker CD68 to examine the 
purity of the macrophage culture. More than 95% of cells were positive for CD68 suggesting a high 
purity of the alveolar macrophage preparation.  
 
2.2.6 Indirect immunofluorescence 
Cells were plated on coverslips and allowed to grow overnight. 12 h after 
treatment with LPS or LPS+LFMA13, the coverslips were rinsed with PBS (pH 
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7.4) and fixed with 4% paraformaldehyde (PFA) in PBS for 20min at RT. 
Thereafter, the cells were washed three times with PBS. Then the coverslips 
containing the cells were incubated for 10min in PBS containing 1% glycine and 
for an additional 10min in PBS containing 1% glycine and 0.3% Triton X-100 for 
permeabilization. After washing with PBS, the blocking step to block nonspecific 
protein binding sites was performed by incubating the cells for 30min in PBS 
containing 1% BSA and 0.05% Tween 20. After blocking, the coverslips were 
incubated with primary antibodies overnight at 4°C in a moist chamber, followed 
by extensive washing with PBS (3α5min) and incubation with secondary 
antibodies for 1h at RT. Nuclei were counterstained with Hoechst 33342 (2 
µg/ml) (Vijayan et al. 2011).  
2.2.7 Flowcytometric Analysis of ROS 
MEFs: dihydroethidium (DHE) dye (Invitrogen) was used to detect the 
generation of intracellular ROS. Upon accumulation of ROS, DHE is cleaved to 
form the fluorescent byproduct ethidium, which was detected with a flow 
cytometer. Cells were first incubated in the presence or absence of SB 202190 
(10 µM) for 1 h, followed by further incubation with 5 µM DHE for 20 min. After 
washing, the levels of ROS were determined with a FACScalibur flow cytometer. 
DHE-detectable (FL2-H) fluorescent signals were displayed as histograms (Naidu 
et al. 2009).  
RAW264.7 cells: intracellular generation of ROS was detected with 
dichlorodihydrofluorescein diacetate (H2-DCFDA) dye (Invitrogen). Fluorescent 
ROS-modified H2DCFDA byproduct dichlorofluorescein, which is
 produced after 
oxidation and cleavage by cellular esterases, was detected with a flow 
cytometer. After pre-incubation with LFM-A13 for 1 h followed by addition of LPS 
37 
 
for another 9 h, 1x106 cells were incubated at 37°C for 30 min in medium 
containing 15 M H2-DCFDA. Cells were thereafter washed with PBS and the 
levels of ROS-oxidized DCFDA were determined with a FACSCalibur flow 
cytometer. In NAC experiments, cells were first treated with LPS for 9 h followed 
by 1h NAC treatment. DCF-detectable (FL1-H) fluorescent signals were displayed 
as histograms (not shown). Ratios of signals versus control data were calculated 
using mean fluorescence intensity (Vijayan et al. 2011). 
2.2.8 Nitrite Assay  
Griess reagent assay kit from Promega was used to detect nitrite levels in the 
samples. Briefly, the medium from treated and untreated cells were collected 
and centrifuged. 50l of sulfinilamide solution was added to 50 l of the sample 
medium in a 96 well plate and incubated for 10 min followed by addition of 50l 
of N-(1-naphthyl)-ethylenediamine dihydrochloride. The plate was further 
incubated for 10 min and the absorbance was read at 550nm. The nitrite level in 
each sample was calculated from a standard generated with sodium nitrite (0-
300 M) (Vijayan et al. 2011). 
2.2.9 Methylthiazole tetrazolium (MTT) assay 
The effect of heme treatment on the viability of RAW264.7 macrophages was 
evaluated by the MTT assay (Sigma). Briefly, after pretreatment with LFM-A13 
for 1 h cells were incubated with heme for additional 14 h. Cells were then 
washed, incubated with 0.5 mg/ml MTT in Dulbecco’s modified Eagle’s medium 
(without phenol red) for 2 h. The MTT-transformed formazan crystals formed in 
viable metabolic cells were dissolved in dimethyl sulfoxide and absorbance read 
at 570 nm using a spectrophotometer. The percentage of cell viability was 
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calculated by the following formula: A570 of treated cell/A570 of non-treated cells 
x 100 (Vijayan et al. 2011). 
2.2.10 RNA expression analysis by realtime-RT-PCR 
2.2.10.1 RNA isolation 
Total RNA isolation from cells was performed using the RNeasy Mini Kit from 
Qiagen. Homogenization of cells in RLT buffer was performed by passing the 
lysate through a 22G needle attached to a 1 ml syringe several times. RNA 
extraction was carried out with the Qiagen RNeasy Mini kit according to the 
manufacturer’s protocol. The isolated RNA was redissolved in RNase free water 
and stored at -80°C till used. The quantity of the isolated RNA was measured by 
optical density measurements using a Bio-Rad spectrophotometer. The integrity 
of the RNA was analyzed by visualization of ethidium bromide-stained intact 28S, 
18S and 5S ribosomal RNA bands in 1% denaturing formaldehyde agarose gels.  
2.2.10.2 DNase I digestion 
Before the samples were used for reverse transcription, a DNase I digestion step 
was performed to remove residual genomic DNA in the RNA preparation. To the 
prepared DNase digestion mixture, 1 µg of the RNA sample was added and 
incubated for 15min at RT after which the DNase I was inactivated by the 
addition of 1 µl of 25mM EDTA followed by heating for 10min at 65°C.  
    DNase digestion of RNA samples 
 
 
 
RNA sample 1 µg 
10X DNase I reaction buffer 1 µl 
DNase I, amplification grade, 1U/µl 1 µl 
DEPC-treated water to 10 µl 
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2.2.10.3 Reverse transcription  
 0.5 µg oligo (dT) 12-18 primers and 10mM dNTP mixtures were used along with 
total RNA (0.5 - 1 µg) for reverse-transcription into cDNA as described below.  
Oligo(dT)12-18 (500 µg/ml) 1 µl 
RNA (1 µg) ~ 10 µl 
dNTP mixture (10mM each) 1 µl 
Sterile distilled water to 12 µl 
 
The denaturation step was done by heating the RNA mixture to 65°C for 5min 
followed by immediate incubation on ice. Thereafter, 4 µl of 5X first strand 
buffer, 2 µl of 0.1M DTT and 1 µl of RNaseOUTTM (40U/µl) were added to the 
reaction mixture.The reaction mixture was mixed thoroughly and incubated at 
42°C for 2min. 1 µl of SuperScriptTM II Reverse Transcriptase (200U) was added 
to the mixture and the reaction tubes were incubated at 42°C for 50min for 
reverse transcription. Finally, the samples were heated at 70°C for 15min for 
inactivation of the reaction. 
Amplification was performed using TaqMan Gene Expression Master Mix on a 
StepOnePlus™ Real-Time PCR System (Applied Biosystems) according to the 
manufacturer’s instructions. Thermal cycling was performed at 95°C for 10 min 
followed by 40 cycles at 95°C for 15 sec and 60°C for 1 min. The constitutively 
expressed gene, 28srRNA was used as a control for normalization of cDNA 
levels. The ΔΔCT method was used to semiquantify mRNA levels, according to 
the manufacturer's protocol. 
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2.2.11 Western Blot analysis 
2.2.11.1 Isolation of whole cell lysates  
After washing cell cultures twice with 1XPBS, 150 µl of cell lysis buffer was 
added to each well. Cells were scraped thoroughly using a rubber policeman and 
transferred to eppendorff tubes. The tubes were kept on ice for 30 min with 
vortexing at intervals. The tubes were then centrifuged for 30 min at maximum 
speed for 30 min at 4oc after which supernatant was collected and stored at -20 
oc. 
2.2.11.2 Preparation of Western blots 
Concentration of the protein samples were determined by the Bradford method 
using BSA as a standard (Bradford 1976). The protein samples (30-50 µg) were 
separated on 12% SDS polyacrylamide gels and then transferred onto 
polyvinylidene fluoride (PVDF) membranes. The membranes were incubated at 
RT with shaking in Tris-buffered saline (TBS) containing 10% nonfat milk powder 
and 0.05% Tween-20 for 1h to block nonspecific protein-binding sites. 
Thereafter, the membranes were incubated with the primary antibody overnight 
at 4°C or for 1h at RT. Following the primary antibody incubation, the 
membranes were washed 3 times and then incubated with alkaline phosphatase-
conjugated secondary antibody for 1h at RT. Immun-StarTM AP substrate from 
Bio-Rad (Munchen, Germany) was used to detect the alkaline phosphatase 
activity and the blots were exposed to Kodak Biomax MR Films. Blots were 
scanned using an AGFA scanner. All Western blot experiments were performed 
and analyzed at least three times. 
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2.2.12 Statistical Analysis 
Each result is a representative of at least three experiments. Student's paired t 
test was done to compare the control cells with the treated cells and the data is 
represented as average +/- standard mean error (SEM). P values of 0.05 or less 
were considered significant. 
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3 RESULTS 
The results of this thesis are divided into two parts (Chapter I and Chapter II) that were 
published in the Journal of Immunology and the pubmed Ids of the following are (I) 
PMID: 21677132 and (II) PMID: 19454702 
(I) Vijayan, V., E. Baumgart-Vogt, S. Naidu, G. Qian and S. Immenschuh (2011). 
"Bruton's tyrosine kinase is required for TLR-dependent heme oxygenase-1 gene 
activation via Nrf2 in macrophages." J Immunol 187(2): 817-27. 
 
(II) Naidu, S., V. Vijayan, S. Santoso, T. Kietzmann and S. Immenschuh (2009). 
"Inhibition and genetic deficiency of p38 MAPK up-regulates heme oxygenase-1 gene 
expression via Nrf2." J Immunol 182(11): 7048-57 
 
PART-I: Btk-mediated regulation of the HO-1 gene 
3.1 LPS-dependent HO-1 gene induction is reduced by the 
pharmacological Btk inhibitor LFM-A13 
LPS, a proinflammatory mediator induce signaling in macrophages by binding to 
TLR4. It has been shown earlier that LPS upregulates HO-1 gene expression in 
mononuclear phagocytes such as monocytes and macrophages (Camhi et al. 
1995; Immenschuh et al. 1999; Horwood et al. 2003; Wijayanti et al. 2004; 
Rushworth et al. 2005; Schmidt et al. 2006). Herein, we determined the effect of 
LFM-A13, an inhibitor of Btk which belongs to the tec family of kinases, on LPS-
dependent HO-1 induction in the mouse macrophage cell line RAW264.7. Btk has 
previously been shown to differentially regulate gene expression in 
myeloid/macrophage cells (for a review see (Koprulu and Ellmeier 2009). 
RAW264.7 cells are known to express Btk (Jongstra-Bilen et al. 2008) and 
pretreatment with LFM-A13 blocked the LPS-induced protein expression of HO-1.  
LPS-dependent COX-2 induction which is another early-induced proinflammatory 
gene in macrophages was not significantly affected by LFM-A13 (Fig. 7A) 
treatment. Real-time RT-PCR studies revealed that pretreatment of RAW264.7 
cells with LFM-A13 markedly downregulated the LPS-induced HO-1 mRNA 
expression (Fig. 7B). In a previous study LFM-A13 was shown to inhibit JAK2 
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which belongs to the family of Janus kinases. To rule out the possibility that, the 
observed effect of LFM-A13 on LPS-dependent HO-1 induction is due to JAK2 
inhibition, we used a specific JAK2 inhibitor AG490 in RAW264.7 cells. However, 
addition of AG490 already, led to a significant upregulation of HO-1 gene 
expression in dose-dependent manner (Fig. 7C). 
  
 
 
 
 
 
 
 
 
Figure 7: Effect of LFM-A13 on LPS-dependent induction of HO-1 gene expression in cell 
cultures of RAW264.7 cells and mouse alveolar macrophages 
RAW264.7 cells and mouse alveolar macrophages were cultured as described under Materials and 
Methods. A: RAW264.7 cells were pretreated with LFM-A13 (100 µM) for 1 h, after which incubation 
was continued with or without LPS (1 µg/ml) for another 18 h, as indicated. Total protein (30 
µg) was subjected to Western blot analysis and sequentially probed with Antibodies against HO-1, 
COX-2 and GAPDH. Autoradiographic signals were visualized and quantified as described under 
Materials and Methods. Values  SEM represent the fold induction of HO-1 normalized to GAPDH 
from three independent experiments. B: RAW264.7 cells were treated with LFM-A13 (100 µM) for 1 h, 
after which treatment was continued with or without LPS (1 µg/ml) for another 12 h, as indicated. 
One µg of RNA was used for real-time RT-PCR analysis with HO-1 and GAPDH primers as described 
in Materials and Methods. C: RAW264.7 cells were treated with AG490 at the indicated concentrations 
for 12 h (result not shown in Vijayan et al, 2011). Total protein (30 µg) was subjected to Western 
blot analysis and sequentially probed with antibodies against HO-1 and GAPDH. Statistics: Student’s t-
test for paired values:  *: significant differences treatment versus control; **: LPS versus LPS+LFM-
A13, p ≤ 0.05. [published as Figure number 1 A and 1 B in Vijayan et al, 2011] 
 
 
A 
B 
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Figure 8: Effect of LFM-A13 on LPS-mediated induction of HO-1 gene expression in cell 
cultures of mouse alveolar macrophages. 
A-H: mouse alveolar macrophages were pretreated with LFM-A13 (100 µM) for 1 h, after which 
treatment was continued with or without LPS (1 µg/ml) for another 12 h, as indicated. Cells were then 
subjected to IF staining using a HO-1 antibody at a dilution of 1:4,000 and nuclei were visualized with 
Hoechst 33342 dye as described in Materials and Methods. LFM: LFM-A13; H33342: Hoechst 33342. 
Bar = 560 m. [Published as figure number 1 C-J in Vijayan et al, 2011 ] 
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In the following, we investigated the effect of LFM-A13 on LPS-mediated HO-1 
induction in cell cultures of primary mouse alveolar macrophages. As determined 
by immunofluorescence (IF) studies, LPS stimulation of alveolar macrophages 
caused a significant increase of HO-1 protein expression. The upregulation of 
HO-1 by LPS was attenuated when cells were pretreated with LFM-A13 (Fig. 8A-
H). In conclusion, the data indicate that specific inhibition of Btk with LFM-A13 
markedly reduces LPS-dependent induction of HO-1 
3.2 Induction of HO-1 upregulation is blocked in alveolar macrophages 
from Btk-/- mice 
To further investigate the role of Btk, we compared the effect of LPS on HO-1 
induction in cell cultures of alveolar macrophages from Btk-/- mice and thier 
wildtype littermates. In contrast to a pronounced induction of HO-1 gene 
expression in LPS-treated macrophages from wild type mice, only a weak 
staining for HO-1 protein was observed in cells from Btk knockout mice in 
response to LPS (Fig. 9A-H). In addition, studies with real time rtPCR studies 
showed a marked upregulation of HO-1 mRNA levels upon LPS stimulation in cell 
cultures of alveolar macrophages from wild type mice, but not in those from Btk 
deficient mice (Fig. 10). The data confirm that Btk plays a major regulatory role 
in LPS-dependent induction of HO-1 gene expression in primary murine 
macrophages. 
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Figure 9: LPS-dependent induction of HO-1 is blocked in alveolar macrophages from 
Btk-/- mice. 
A-H: cell cultures of alveolar macrophages from Btk-/- mice and from their wild-type littermates were 
incubated with or without LPS (1 µg/ml) for 12 h. Cells were then subjected to IF staining with a 
HO-1 antibody at a dilution of 1:4,000 and nuclei were visualized with Hoechst 33342 dye. Btk ko: 
Btk knockout; H33342: Hoechst 33342; WT, wild-type. Bar = 560 m.  [Published as figure number 2 
A-H in Vijayan et al, 2011] 
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Figure 10: LPS-dependent induction of HO-1 is blocked in alveolar macrophages from 
Btk-/- mice. 
Mouse alveolar macrophages were treated with LPS (1 µg/ml) for 12 h and the RNA was isolated for 
real-time RT-PCR analysis using the primers for HO-1 and GAPDH as described in Materials and 
Methods. Statistics: Student’s t-test for paired values: *: significant differences treatment versus 
control, **: LPS treatment in Btk+/+ versus LPS treatment in Btk-/- p ≤ 0.05. [Published as figure 
number 2I in Vijayan et al, 2011] 
 
3.3 Btk-dependent induction of HO-1 by LPS is mediated via a 
transcriptional mechanism 
HO-1 expression by most stimuli is mainly regulated at the transcriptional level 
(Choi and Alam 1996; Paine et al. 2010). Luciferase gene reporter studies were 
performed to further elucidate the mechanisms by which Btk mediate LPS-
dependent induction of HO-1. RAW264.7 cells were transiently transfected with a 
reporter gene construct containing the proximal 4,045 bp of the mouse HO-1 
gene promoter (pHO-4045-luc) and then treated with LFM-A13 prior to LPS 
exposure. Luciferase activity of pHO-4045-luc was induced in response to LPS 
and pretreatment with LFM-A13 significantly reduced the luciferase activity of 
the pHO-4045-luc (Fig. 11A). By contrast, LPS-dependent upregulation of the 
luciferase activity of pTNF-585-luc, a plasmid containing the proximal 585 bp of 
the TNF-α gene promoter region, was not affected by LFM-A13 treatment (Fig. 
11A). 
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A major target of Btk-mediated TLR4 signaling is the transcription factor NF-B 
(Jefferies and O'Neill 2004). Since NF-B has previously been shown to regulate 
HO-1 gene expression (Wijayanti et al. 2004; Naidu et al. 2008), we compared 
the effect of LFM-A13 on the classical pathway of NF-B activation, that occurs 
via the phosphorylation of the NF-Binhibitory protein IB subunit, followed by 
the degradation of IB. LPS treatment led to phosphorylation and degradation of 
IB in RAW264.7 cells and pretreatment with LFM-A13 did not affect the 
phosphorylation and degradation of IB (Fig. 11B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Btk is required for LPS-dependent induction of mouse HO-1 promoter 
activity. 
A: RAW264.7 cells were transfected with the indicated luciferase reporter gene vectors as described in 
Materials and Methods. 24 h after transfection, cells were treated with LFM-A13 (100 µM) for 1 h 
before incubation was continued with or without LPS (1 µg/ml) for 18 h. Cell extracts were 
collected and assayed for luciferase activity. Statistics: Student’s t-test for paired values: *: 
significant differences treatment versus control; **: LPS versus LPS+LFM-A13, p ≤ 0.05. B: 
RAW264.7 cells were treated with or without LFM-A13 (100 µM) for 1 h followed by treatment with 
A 
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49 
 
LPS (1 µg/ml) for the indicated times. Western  blot  analysis  was  performed  with  antibodies  to  
phospho-IB-alpha,  total  IB  and  GAPDH  as described in Fig. 7. [Published as figure number 3A 
and 3B in Vijayan et al, 2011] 
In the following, we cotransfected the pHO-4045-luc construct and an expression 
vector with the dominant negative Btk mutant BtkDN-K430R into RAW264.7 
cells (Doyle et al. 2005). As shown in Fig. 12, overexpression of dominant 
negative Btk downregulated the LPS-induced luciferase activity of the pHO-
4045-luc construct in comparison to cells, which have been co-transfected with 
an empty control vector (Fig. 12). A similar inhibitory effect was also observed in 
cotransfection studies with the dominant-negative mutant BtkDN-R28C (data not 
shown). Taken together, the data indicate that Btk regulates HO-1 induction via 
a transcriptional mechanism that is independent of NF-B.   
 
 
 
 
 
 
 
 
 
 
Figure 12: The dominant negative form of Btk blocked LPS-dependent induction of 
the mouse HO-1 promoter activity. 
RAW264.7 cells were co-transfected with the mouse HO-1 luciferase reporter vector pHO-4045-luc 
or pGL2-basic together with the expression vector BtkDN-K430R or empty control vector 
(pcDNA3.1), as indicated. 24 h after transfection cells were treated with or without LPS (1 µg/ml) for 
another 18 h. Cell extracts were collected and assayed for luciferase activity. Statistics: Student’s t-
test for paired values: *: significant differences treatment versus control; **: LPS versus LPS+LFM-
A13, p ≤ 0.05. LFM: LFM-A13, Btkdn: Btk-DNK430R. [Published as figure number 3C in Vijayan et al, 
2011] 
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3.4 Nrf2 plays a role in Btk-mediated induction of HO-1 by LPS 
Nrf2, is a key transcriptional regulator of the antioxidant response and mediates 
the inducible expression of HO-1 and also that of other phase II detoxification 
and antioxidant genes such as NADPH quinone oxidoreducatse (NQO1) and 
glutathione S-transferase (GST) (Kobayashi and Yamamoto 2005; Kensler et al. 
2007). Nrf2, once activated, translocates to the nucleus and binds to the 
promoter of target genes. Therefore, we performed immunofluorescence studies 
to monitor Nrf2 translocation. As shown in Fig. 13, upon treatment with LPS, the 
immunofluorescence signal in the nuclear areas markedly increased, indicating 
significant translocation of Nrf2 from the cytoplasm into the nucleus of 
RAW264.7 cells (Fig. 13A-D). However, pretreatment of RAW264.7 cell with 
LFM-A13 strongly inhibited the LPS-induced nuclear accumulation of Nrf2 (Fig. 
13E-H).  
To examine the functional relevance of the nuclear translocation of Nrf2, we also 
performed luciferase gene reporter assays with a reporter vector containing the 
antioxidant response element (ARE) (pARE-luc), which is the target sequence of 
Nrf2.  Treatment with LPS caused a marked increase in the luciferase activity of 
this construct and pretreatment with LFM-A13 significantly blocked this induction 
(Fig. 14A). This impaired activation of Nrf2 might not only be relevant to HO-1, 
because LFM-A13 also reduced the LPS-induced mRNA levels of the Nrf2 target 
gene NADPH quinone oxidoreductase (NQO1) (Fig. 14B). Taken together, these 
results indicate that activation of Nrf2 is involved in Btk-dependent upregulation 
of HO-1 by LPS and this Btk-Nrf2-mediated signaling pathway might also 
regulate other LPS-induced antioxidant genes. 
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Figure 13: Nuclear translocation of Nrf2 in response to LPS is downregulated by LFM-
A13. 
A-H: RAW264.7 cells were pretreated with LFM-A13 (100 µM) for 1 h, after which incubation was 
continued with or without LPS (1 µg/ml) for another 9 h, as indicated. Cells were then subjected to 
immunofluorescence staining using an Nrf2 antibody at a dilution of 1:500, and nuclei were visualized 
with Hoechst 33342 dye as described in Materials and Methods. LFM: LFM-A13; H33342: Hoechst 
33342. Bar = 560 m. [Published as figure number 4 A-H in Vijayan et al, 2011] 
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Figure 14: LPS-dependent induction of an ARE-regulated reporter gene construct is 
inhibited by LFM-A13. 
A: RAW264.7 cells were transfected with the indicated luciferase reporter gene vectors as described in 
Materials and Methods. 24 h after transfection, cells were pretreated with LFM-A13 (100 µM) for 1 
h, after which incubation was continued with or without LPS (1 µg/ml) for another 18 h, as indicated. 
Cell extracts were collected and assayed for luciferase activity. B: RAW264.7 cells were pretreated 
with LFM- A13 (100 µM) for 1 h, after which treatment was continued with or without LPS (1 µg/ml) 
for another 12 h, as indicated. One µg of RNA was used for real-time RT-PCR analysis with NQO1 
and GAPDH primers as described in Materials and Methods. Statistics: Student’s t-test for paired 
values: *: significant differences treatment versus control; **: LPS versus LPS+LFM-A13, p ≤ 0.05. 
LFM: LFM-A13. [Published as figure number 5A and 5B in Vijayan et al, 2011] 
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3.5 LPS-dependent production of ROS is involved in Btk-mediated 
upregulation of HO-1 in macrophages 
The lack of Btk has previously been shown to cause an attenuated production of 
ROS and NO in immunostimulated mononuclear phagocytes from Btk-deficient 
mice (Mangla et al. 2004). Since Nrf2-dependent induction of HO-1 is known to 
be regulated by prooxidant cellular conditions, we investigated the possibility 
that cellular levels of ROS might be affected by the activation of Btk. To this end 
we determined cellular levels of ROS in response to LPS in RAW264.7 cells with 
and without pharmacological inhibition of Btk by LFM-A13. As determined with a 
flow cytometry-based assay, LPS upregulated the production of ROS and 
pretreatment with LFM-A13 blocked the LPS-induced production of ROS and 
addition of the anti-oxidant N-Acetyl cysteine (NAC) attenuated the production of 
LPS-induced ROS (Fig. 15A). We also examined the LPS-induced levels of NO in 
RAW264.7 cells after pre-treatment with the Btk inhibitor LFM-A13 by measuring 
the amount of nitrite levels in the cell culture media. As expected, LPS markedly 
induced the amount of nitrite in the supernatant, which was blocked by 
pretreatment with LFM-A13. Addition of the specific iNOS inhibitor 1,400W 
abolished the LPS-induced production of NO (Fig. 15B). Moreover, LFM-A13 also 
blocked the LPS-induced gene expression of iNOS (Fig. 15C). Taken together 
these results indicate that inhibition of Btk impairs the LPS-induced production of 
ROS and that of NO in RAW264.7 cells. Finally, to evaluate the role of ROS and 
NO in LPS-induced activation of Nrf2, RAW264.7 cells were transfected with 
pARE-luc and were pretreated with NAC or 1,400W before exposure to LPS. LPS-
induced luciferase activity of pARE-luc was markedly reduced in these cells by 
(NAC), but not by pretreatment with 1400W (Fig. 15D). Furthermore, LPS-
dependent induction of HO-1 was blocked when the cells were pretreated with 
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NAC. In summary, Btk-dependent HO-1 activation via Nrf2 is mediated via the 
production of ROS in LPS-stimulated macrophages. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: Role of ROS in Btk-mediated induction of HO-1 by LPS. 
A: RAW264.7 cells were treated for 9 h with LFM-A13 (100 µM) and LPS (1 µg/ml) alone or in 
combination, as indicated. After 9 h of incubation NAC (25 mM) was added and treatment was 
continued for 1 h, as indicated. Cells were washed, incubated with H2DCFDA dye for 30 min and 
A 
B 
C 
D 
 
 
 
 
55 
 
analyzed by flow cytometry as described in Materials and Methods. Numbers indicated represent mean 
fluorescence intensity relative to control cells from at least three independent experiments SEM. 
Statistics: Student’s t-test for paired values: *: significant differences treatment versus control; 
**: LPS versus LPS+LFM-A13; ***: LPS versus LPS+NAC, p ≤ 0.05. B: RAW264.7 cells were 
pretreated with or without LFM-A13 (100 µM) for 1 h or 1400W (500 µM) for 30 min, after which 
incubation was continued with LPS (1 µg/ml) for 18 h, as indicated. The supernatant was collected 
and assayed for nitrite as described in Materials and Methods.  Statistics: Student’s t-test for paired 
values:  *: significant differences treatment versus control; **: LPS versus LPS+LFM-A13; ***: LPS 
versus LPS+1400W, p ≤ 0.05. C: RAW264.7 cells were pretreated with LFM-A13 (100 µM) for 1 h 
followed by treatment with LPS (1 µg/ml) for another 12 h. Total protein (30 µg) was subjected to 
Western blot analysis and was sequentially probed with antibodies against iNOS and GAPDH. D: 
RAW264.7 cells were transfected with the indicated luciferase reporter gene vectors as described 
before. 24 h after transfection, cells were pretreated with NAC (25 mM) or 1400W (500 µM) for 30 
min followed by incubation with or without LPS (1 µg/ml) for another 18 h. Cell extracts were 
collected and assayed for luciferase activity. Statistics: Student’s t-test for paired values: *: 
significant differences treatment versus control; **: LPS versus LPS+NAC, p ≤ 0.05. LFM: LFM-A13. 
[Published as figure number 6A-D in Vijayan et al, 2011] 
3.6 Btk mediates HO-1 induction in macrophages upon stimulation with 
various TLR ligands 
Btk has previously been shown to be involved in signaling by other TLRs, such as 
TLR3, TLR7 and TLR9 in myeloid cells (Doyle et al. 2007; Taneichi et al. 2008). 
As shown in Fig. 16, treatment with both TLR7 and TLR9 ligands (R837 and 
ODN2395) upregulated HO-1 expression. However, pretreatment with LFM-A13 
largely reduced this induction (Fig. 16). Next, we also examined whether TLR7 
and TLR9 ligands (R837 and ODN2395) would activate pARE-luc construct in 
transiently transfected RAW264.7 cells. Both TLR7 and TLR9 ligands up-
regulated reporter gene activity of pARE-luc, but the level of induction was lower 
as compared to TLR4 activation by LPS (Fig. 17A). Similar to the regulation of 
HO-1 protein, pretreatment with LFM-A13 reduced the induction of pARE-luc 
activity in response to TLR7 and TLR9 ligands, respectively.  
In the following, we also investigated whether gene expression of HO-1 by other 
TLRs such as TLR2, TLR3, TLR5 and TLR6 is also mediated via Btk. RAW264.7 
cells were treated with the TLR-ligands LTA (TLR2/6), polyI:C (TLR3) and 
flagellin (TLR5) in the presence or absence of treatment with LFM-A13 and HO-1 
expression was determined by real-time RT-PCR. As shown in Figure 17B, only 
the TLR2 ligand LTA upregulated HO-1 mRNA expression and the level of 
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induction was similar to that of treatment with LPS. Pretreatment with LFM-A13 
completely blocked this induction. By contrast, both polyI:C and flagellin failed 
to induce HO-1 gene expression (Fig. 17B). In summary, our findings suggest 
that HO-1 upregulation by activation of TLRs 2, 4, 6, 7 and 9 is mediated via Btk 
in macrophages. 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: LFM-A13 inhibits HO-1 induction RAW264.7 cells that are stimulated by different 
TLR ligands. 
RAW 264.7 cells were pretreated with LFM-A13 (100 µM) for 1 h and incubation was continued with or 
without R848 (3 µg/ml) or ODN2395 (3 µg/ml) for another 18 h, as indicated. Total protein (30 µg) was 
subjected to Western blot analysis and was sequentially probed with antibodies against HO-1 and 
GAPDH. Autoradiographic signals were visualized and quantified as described in Materials and Methods. 
Statistics, Student’s t-test for paired values: *: significant differences treatment versus control; **: 
LPS/R848/ODN2395 versus LPS/R848/ODN2395+LFM-A13, p ≤ 0.05. LFM: LFM-A13; ODN: ODN 2395. 
[Published as figure number 7A in Vijayan et al, 2011] 
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Figure 17: LFM-A13 inhibits HO-1 induction RAW264.7 cells that are stimulated by various 
TLR ligands. 
A: RAW 264.7 cells were transfected with the luciferase reporter vector p-ARE-luc as described in 
Materials and Methods. 24 h after transfection, cells were treated with (grey bars) or without (black 
bars) LFM-A13 (100 µM) for 1 h followed by incubation with LPS (1 µg/ml), R848 (3 µg/ml) or ODN2395 
(3 µg/ml) for another 18 h, as indicated. Cell extracts were collected and assayed for luciferase activity. 
Statistics, Student’s t-test for paired values: *: significant differences treatment versus control; **: 
LPS/R848/ODN2395 versus LPS/R848/ODN2395+LFM-A13, p ≤ 0.05. LFM: LFM-A13; ODN: ODN 2395. 
B: RAW264.7 cells were treated with LFM-A13 (100 µM) for 1 h, after which treatment was continued 
with or without LPS (1 µg/ml), LTA (5 µg/ml), flagellin (10 nM) or poly I:C (25 µg/ml)  for another 12 h, 
as indicated. One µg of RNA was used for real-time RT-PCR analysis as described in Materials and 
Methods. Statistics, Student’s t-test for paired values: *: significant differences treatment versus 
control; **: LPS/ LTA/ poly I:C/ flagellin versus LPS/ LTA/ poly I:C/ flagellin +LFM-A13, p ≤ 0.05. LFM: 
LFM-A13. [Published as figure number 7B and 7C in Vijayan et al, 2011] 
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3.7 Increased sensitivity to heme-induced toxicity after treatment with 
LFM-A13 
Free heme has been shown to be a TLR4 ligand and to play an important role in 
sepsis-induced inflammatory damage and induction of HO-1 provides protection 
against heme-mediated toxicity. Hence, we chose to examine the protective 
effects of Btk mediated HO-1 regulation against heme in our cell culture model. 
RAW264.7 cells were treated with high concentration of heme in the presence or 
absence of LFM-A13 and cytotoxicity was measured with an MTT assay. 
Treatment with high concentration of heme reduced the viability of cells by 30%. 
Interestingly cells pretreated with LFM-A13 were drastically sensitive to heme 
treatment with almost 75% increase in the number of dead cells in comparison 
to the control untreated cells (Fig. 18). The data indicate that specific inhibition 
of Btk in macrophages renders these cells highly sensitive to heme-induced 
oxidative stress. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Increased sensitivity to heme-dependent 
toxicity in LFM-A13-treated RAW264.7 cells 
 RAW 264.7 cells were pretreated with LFM-A13 (100 µM) 
for 1 h and incubation was continued with or without heme 
(30µM) for another 16 h, as indicated. Samples were 
subjected to MTT assay as described in Materials and 
Methods. Statistics: Student’s t-test for paired values: *: 
significant differences treatment versus control; **: heme 
control versus heme +LFM-A13, p ≤ 0.05. LFM: LFM-A13. 
[Published as figure number 8 in Vijayan et al, 2011] 
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PART-II: p38 MAPK-mediated regulation of the HO-1 gene 
3.8 Pharmacological inhibition and genetic deficiency of p38 MAPK lead 
to upregulation of HO-1 
As reported earlier (Wijayanti et al. 2004; Naidu et al. 2008) treatment with the 
phorbol ester PMA induced the expression of HO-1 and COX-2 in cell cultures of 
RAW264.7 macrophages (Fig. 19). 
 
 
 
 
 
Figure 19:  Upregulation of COX-2 and HO-1 gene expression in RAW264.7 cells treated 
with LPS and PMA. 
RAW264.7 cells were treated with or without PMA (0.5 µM) or LPS (1 µg / ml) for 18 h. Total 
protein (50 µg) was subjected to Western blot analysis and probed sequentially with antibodies 
against HO-1, Cox-2 and GAPDH. [Published as Figure 1A in Naidu et al, 2009]  
 
 Previously, it was reported that p38 MAPK mediate the PMA-dependent 
induction of HO-1 and COX-2 (Schuette and LaPointe 2000; Chen et al. 2003; 
Wijayanti et al. 2004; Naidu et al. 2008). As expected, pretreatment of 
RAW264.7 cells with SB 202190, a specific inhibitor of p38α and p38β MAPK 
activity, blocked the PMA-dependent induction of HO-1. However, interestingly 
treatment with this compound alone markedly induced HO-1 (Fig. 20A). Indeed, 
the following experiments showed that SB202190 upregulated HO-1 in a time 
dependent manner (Fig. 20B). Similarly a strong induction of HO-1 was also 
observed when a second p38 inhibitor SB203580 was used (Fig. 20B).  
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To confirm this unexpected finding we compared PMA-dependent induction of 
HO-1 and Cox-2 gene expression in cell cultures of MEF, that were genetically 
deficient for p38α (p38α-/- MEF) in comparison to that in wild-type MEF (p38α+/+ 
MEF). As observed in RAW264.7 macrophages, treatment with PMA upregulated 
HO-1 and Cox-2 expression in p38α+/+ MEF. Whereas in p38α-/- MEF treatment 
with PMA had little effect on HO-1 and COX-2 expression. It is also noteworthy 
that the basal level of HO-1 protein expression was markedly higher in p38α-/- 
MEF in comparison to that of p38α+/+ MEF (Fig. 20C). The results indicate that 
the loss of p38 function causes an increased expression of the HO-1 gene. 
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Figure 20: Pharmacological inhibition and genetic deficiency of p38 induce HO-1 gene 
expression 
A: RAW264.7 cells were pretreated for 30 min with SB 202190 (5 and 10 µM), after which treatment 
was continued for another 6 h with or without PMA (0.5 µM), as indicated. B: RAW264.7 cells were 
treated with SB 202190 (10 µM), SB 203580 (20 µM) for the times indicated. C: p38+/+ and p38-/- 
MEF were treated for 18 h with or without PMA (0.5 µM), as indicated. Total protein (50 µg) was 
subjected to Western blot analysis and probed sequentially with antibodies against HO-1, Cox-2 and 
GAPDH. Autoradiographic signals were visualized and quantified as described under Materials 
and Methods. (A) Values  SEM represent the fold induction of HO-1 normalized to GAPDH from 
three independent experiments. (C) Numbers represent the protein expression levels relative to 
p38+/+ MEF normalized to GAPDH from at least three independent experiments  SEM. Statistics: 
Student’s t-test for paired values: *: significant differences treatment versus control; **: p38+/+ 
control versus p38-/- control, p ≤ 0.05. RAW: RAW264.7 cells. [Published as figure 1B, 1C and 1F in 
Naidu et al, 2009] 
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3.9 Constitutive activation of p38 MAPK in RAW264.7 cells 
The findings that p38α-/- MEF  possesses an increased expression of HO-1 and 
pharmacological inhibition of p38 in RAW264.7 cells leads to the upregulation of 
HO-1 indicate that in the basal state in RAW264.7 cells p38 MAPK may already 
be active. To test this hypothesis, we determined p38 activity in untreated 
RAW264.7 cells. As expected, p38 phosphorylation, which is a sign for 
activation, was detected under basal conditions and treatment with SB 202190 
and SB 203580 abrogated this phosphorylation (Fig. 21A). To verify the 
functionality of p38 MAPK in detail, we performed a cotransfection assay in 
RAW264.7 cells, in which a luciferase reporter construct containing five binding 
sites for the yeast transcription factor Gal4 was used along with a construct 
which express a fusion protein consisting of the Gal4 DNA-binding domain and 
the transactivation domain of the transcription factor CHOP (pFA-CHOP). 
Transactivation of CHOP is regulated by p38-dependent phosphorylation (Wang 
and Ron 1996). The luciferase activity of pFA-CHOP was significantly high in 
RAW264.7 under basal conditions and treatment with p38 inhibitors blocked this 
effect (Fig. 21B). Similarly, the luciferase activity of pFA CHOP was higher in 
p38+/+ MEF in comparison to p38α -/- MEF. As observed in RAW264.7 cells, 
treatement with SB 202190 and SB 203580  significantly blocked the high 
luciferase activity observed in p38α +/+ MEF (Figure 21C). The data demonstrate 
that p38 MAPK is constitutively active in RAW264.7 monocytic cells. 
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Figure 21:  p38 MAPK activity in RAW264.7 and MEF cell cultures 
A: RAW264.7 cells were treated with or without SB 202190 and SB 203580 for the times indicated. 
Total protein (50 µg) was used for Western blot analysis and sequentially probed with antibodies 
against phospho-specific p38 and total p38 MAPK. The results were reproduced at least three times in 
independent experiments. B-C: RAW264.7 cells and p38+/+, p38-/- MEF were cotransfected with 
luciferase reporter gene construct pGal4-luc, pFC2-dbd, and pFA-CHOP, as indicated. 24 h after 
transfection cells were treated with SB 202190 (10 µM) and SB 203580 (20 µM) for 18 h. Cell extracts 
were assayed for luciferase activity, and the fold-induction relative to the control was determined. 
Values are means ± SEM from at least three independent experiments with duplicates of each point. 
Statistics: Student's t-test for paired values: *: significant differences pFC2-dbd versus pFA- CHOP; 
**: treatment versus control, p < 0.05. [Published as figure 2A-C in Naidu et al, 2009] 
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3.10 The HO-1 gene expression is not affected by inhibitors of JNK and 
ERK  
To evaluate the role of MAP Kinases JNK and ERK in the regulation of HO-1 
expression under basal conditions, RAW264.7 cells were treated with the JNK 
specific inhibitor SP 600125, and the ERK specific inhibitor, PD 98059, 
respectively. Unlike p38 inhibitors, treatment with neither the JNK inhibitor SP 
600125 nor the ERK inhibitor PD 98059 induced the expression of the HO-1 gene 
(Fig. 22).  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22: HO-1 gene expression on treatment with JNK and ERK inhibitors 
RAW264.7 cells were treated with or without SB 202190, SP 600125, PD 98059 and PMA at the 
indicated concentrations (µM). Western blot analysis and quantitation was performed as 
previously described. Values ± SEM represent the fold-induction of HO-1 normalized to GAPDH 
from three independent experiments. Statistics: Student’s t-test for paired values: *: significant 
differences treatment versus control, p < 0.05. [Published as figure 3 in Naidu et al, 2009] 
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3.11 Pharmacological inhibition and genetic deficiency of p38 
upregulates HO-1 gene promoter activity 
Nrf2, as mentioned earlier is a member of the cap’n’collar family of basic leucine 
zipper proteins (Motohashi and Yamamoto 2004; Kensler et al. 2007) and plays 
a major role in the regulation of HO-1 expression by various stimuli (Alam et al. 
1999; Ishii et al. 2000). Previously, p38 was reported to be involved in the 
regulation of Nrf2 activation. However, the precise signaling mechanism is not 
well understood (Nguyen et al. 2003). The luciferase reporter gene constructs 
pHO-4045-luc and pE2-luc, both carry the proximal (E1) and distal (E2) 
enhancer sequences of the mouse HO-1 promoter that have been demonstrated 
to be the target sites for Nrf2 on the HO-1 promoter (Alam et al. 1999). To 
further evaluate the relationship between p38 activity and Nrf2 activation, these 
contructs were tranfected into p38-/- and p38+/+ MEF.  Since AP-1 is primarily 
regulated via JNK MAPK, we also transfected p38-/- and p38+/+ MEF with the pAP-
1-luc construct, which carries three copies of the consensus recognition 
sequence of AP-1 (Galang et al. 1994), and this was used as a negative control. 
Basal luciferase activity of the reporter gene construct pHO-4045-luc and pE2-
luc was significantly higher in p38-/- MEF in comparison to that in p38+/+ MEF. As 
expected, no difference was observed in the luciferase activity of pAP-1 luc 
between p38-/- and p38+/+ MEF (Fig. 23A). Moreover, luciferase activity of these 
constructs markedly increased when treated with the p38 inhibitor SB 202190 in 
RAW264.7 cells (Fig. 23B). Taken together, the data indicates that the 
transcription factor Nrf2 is involved in p38-mediated regulation of the HO-1 
gene. 
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Figure 23: Role of p38 MAPK activity in the regulation of the HO-1 promoter. 
A: p38-/- and p38+/+ MEF transfected with the indicated reporter gene constructs were assayed for 
luciferase activity 24 h after transfection. The fold-induction relative to p38+/+ was determined. Values 
are means ± SEM from at least three independent experiments. Student’s t-test for paired values was 
used. *: significant differences p38+/+ versus p38-/-, p < 0.05. B: RAW264.7 cells transfected with the 
indicated reporter gene constructs were assayed for luciferase acitivity 42 h after transfection. 24 h 
after transfection cells were treated with or without SB 202190 (10 µM) as indicated for 18 h. The 
fold- induction relative to the control was determined. Values are means ± SEM from at least three 
independent experiments. Statistics: Student's t-test for paired values: *: significant differences 
treatment versus control, p < 0.05. [Published as figure 4 in Naidu et al, 2009] 
 
3.12 Inhibitors of p38 do not induce HO-1 gene expression in  
Nrf2-/- MEF 
As another independent strategy to analyze the role of p38 in Nrf2-dependent 
HO-1 gene regulation, we treated Nrf2-/- and Nrf2+/+ MEF with p38 inhibitors. 
Treatment with either SB 202190 or SB 203580 markedly upregulated HO-1 
gene expression in Nrf2+/+ MEF but not in Nrf2-/- MEF (Fig. 24).  
 
A 
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Figure 24: Regulation of the HO-1 gene expression in Nrf2-/- and Nrf2+/+ MEF 
Nrf2-/- and Nrf2+/+ MEF were cultured as described under Materials and Methods, and were treated for 
18 h with or without SB 202190 (10 µM) , SB 203580 (20 µM) and PMA (0.5 µM). Western blotting and 
quantitation was performed as described previously in this thesis. Values ± SEM represent the fold- 
induction of HO-1 normalized to GAPDH from three independent experiments. Statistics: Student’s t-
test for paired values: *: significant differences treatment versus control, p < 0.05. [Published as figure 
6A in Naidu et al, 2009] 
 
Similarly, when these cells were transfected with the pHO-4045-luc and pE2-luc 
constructs, the luciferase activity was significantly higher in Nrf2+/+ MEF when 
compared to that in Nrf2-/- MEF (Fig. 25). Moreover, upon treatment with SB 
202190 luciferase activity of two HO-1 gene constructs increased in Nrf2+/+ MEF 
whereas no difference was observed in Nrf2-/- MEF (Fig. 25). As expected, the 
reporter gene activity of the pAP-1-luc construct was not affected by p38 
inhibitors (Fig. 25). Taken together, the results suggest that inhibition of p38-
dependent regulation of the HO-1 gene expression occurs via an Nrf2-dependent 
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manner. Taken together, the results suggest that inhibition of p38-dependent 
regulation of the HO-1 gene expression occurs via an Nrf2-dependent manner. 
 
 
 
 
 
 
 
 
 
 
 
Figure 25: HO-1 promoter activity in Nrf2-/- and Nrf2+/+ MEF 
 Nrf2-/- and Nrf2+/+ MEF were transfected with the indicated reporter gene constructs. 24 h after 
transfection cells were treated with or without SB 202190 (10 µM) and PMA (0.5 µM) for 18 h. The 
luciferase activity of the different constructs were assayed and determined relative to Nrf2-/- MEF. 
Values are means ± SEM from at least three independent experiments with duplicates of each point. 
Statistics: Student's t-test for paired values: *: significant differences treatment versus control; **: 
activity of pHO-4045 or pE2-luc in Nrf2-/- MEF versus Nrf2+/+ MEF, p < 0.05. [Published as figure 6B in 
Naidu et al, 2009] 
 
3.13 ERK is involved in HO-1 gene activation via p38 inhibition 
Independent studies have reported a role for ERK MAPK in the regulation of the 
HO-1 gene by numerous stimuli (Immenschuh and Ramadori 2000; Ryter et al. 
2006). Signaling pathways induced via MAPKs have been shown to involve 
cross-talks (Porras et al. 2004) and so we evaluated the effect of p38 MAPK 
inhibition on the phosphorylation of ERK and whether it plays a role in the 
regulation of HO-1 gene expression in p38-/- and p38+/+ MEF. In comparison to 
p38+/+ MEF, an increased phosphorylation of ERK was observed in p38-/- MEF and 
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presence or absence of serum did not alter this effect (Fig. 26A). Furthermore, 
treatment with the specific ERK inhibitor PD 98059 reduced the increase in the 
protein expression of HO-1 in p38-/- MEF (Fig. 26B). In a second series of 
experiments, the effects of p38 inhibition on the phosphorylation of ERK in 
RAW264.7 cells were examined. Addition of p38 inhibitors to cell cultures of 
RAW264.7 induced the phosphorylation of ERK in these cells (Fig. 26C).  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 26:  Role of ERK activity in p38-dependent regulation of HO-1 gene expression 
A: p38-/- and p38+/+ MEF were cultured in the presence or absence of FCS as indicated B: p38-/- and 
p38+/+ MEF were treated for 6 h in the presence or absence of PD98059. C: RAW 264.7 cells were 
treated with SB 202190 (10 µM), SB 203580 (20 µM) and PMA (0.5 µM), as indicated. Western blot 
analysis was performed as described previously and sequentially probed with antibodies (A, C) against 
phosphorylated ERK and total ERK, (B) HO-1 and GAPDH. [Published as figure 8A-C in Naidu et al, 
2009] 
 
Subsequent transient transfection studies with the luciferase reporter gene 
construct pFA-Elk which is specifically regulated via ERK revealed that the 
A B 
C 
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luciferase activity was strongly upregulated in those cells treated with the p38 
inhibitors. Similarly, treatment with PMA which is known to induce the acitivity of 
ERK MAPK also induced the luciferase activity of pFA-Elk (Fig. 27). In summary, 
the results suggest that deficiency of p38 activity leads to the activation of ERK 
and may be involved in the regulation of the HO-1 gene expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27:  ERK activity in RAW264.7 cells treated with p38 inhibitors 
RAW264.7 cells were cotransfected with the luciferase reporter gene constructs pGal4-luc, pFC2-dbd, 
and pFA-Elk. 24 h after transfection, the cells were treated for 18 h with or without SB 202190 (10 
µM), SB 203580 (20 µM) and PMA (0.5 µM). Luciferase activity in the cell extracts was determined. 
Values are means ± SEM from at least three independent experiments. Statistics: Student's t-test for 
paired values: *: significant differences treatment versus control, p < 0.05. [Published as figure 8D in 
Naidu et al, 2009] 
 
3.14 Genetic deficiency and pharmacological inhibition of p38 MAPK lead 
to increased accumulation of intracellular ROS 
Dolado and co-workers previously reported that genetic deficiency of p38α MAPK  
leads to an increased accumulation of ROS (Dolado et al. 2007). Hence, we 
determined the ROS levels in the p38+/+ and p38-/- MEF. In comparison to p38+/+ 
MEF, p38-/- MEF exhibited significantly higher level of intracellular ROS as 
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measured by FACS (Fig. 28A, B). Furthermore, treatment with the p38 inhibitor 
SB 202190 markedly increased the ROS levels in p38+/+ MEF in comparison to 
the control untreated group (Fig. 28A, B). To evaluate the role for ROS in this 
p38-mediated regulation of HO-1 gene expression, p38+/+ and p38-/- MEF were 
treated with the antioxidant NAC.  
 
 
 
 
 
 
 
 
 
Figure 28: p38 MAPK deficiency leads to increase in intracellular ROS 
A: p38-/- and p38+/+ MEF were treated with SB 202190 (10 µM) for 1 h. Cells were washed and loaded 
with DHE stain (5 µM) for 20 min and after further washing steps analyzed by flow cytometry. B: 
Numbers indicate quantification of the mean fluorescence intensity relative to p38+/+ MEF from at least 
three independent experiments  SEM. Statistics: Student’s t-test for paired values: *: significant 
differences treatment versus control; **: p38+/+ control versus p38-/- control, p < 0.05. [Published as 
figure 9A-B in Naidu et al, 2009] 
 
HO-1 gene expression has been shown to be induced by ROS in immunologically 
active cells (Maines 1997; Immenschuh and Ramadori 2000; Alvarez-Maqueda 
et al. 2004; Naidu et al. 2008). To evaluate the role for ROS in this p38-
mediated regulation of HO-1 gene expression, p38+/+ and p38-/- MEF were 
treated with the antioxidant NAC. The basal expression of HO-1 was significantly 
A B 
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reduced in p38-/- MEF when treated with NAC. Treatment with NAC had little 
effect in p38+/+ MEF (Fig. 29A). In the following RAW264.7 cells were treated 
with NAC prior to the addition of SB 202190. Treatment with NAC blocked the SB 
202190-mediated induction of the HO-1 gene expression. Similarly, upregulation 
of HO-1 by PMA which is a known inducer of ROS production in monocytes 
(Datta et al. 2000) was also attenuated by NAC (Fig. 29B). Taken together these 
results suggest that loss of p38 activity increases the intracellular generation of 
ROS and this might be involved in the induction of the HO-1 gene. 
 
 
 
 
 
 
 
 
 
 Figure 29: p38 MAPK deficiency leads to increase in intracellular ROS 
 A: p38-/- and p38+/+ MEF were treated for 6 h with or without NAC (5 and 25 mM). B: RAW264.7 cells 
were pretreated for 30 min with NAC at the indicated concentrations (mM), after which treatment was 
continued for another 6 h with or without SB 202190 (10 µM) and PMA (0.5 µM). (B) Values ± SEM 
represent the fold-induction of the HO-1 normalized to the GAPDH from three independent 
experiments. Statistics: Student’s t-test for paired values: *: significant differences treatment versus 
control; **: treatment versus NAC + treatment, p < 0.05. [Published as figure 9C-D in Naidu et al, 
2009] 
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4. Discussion 
Hemeoxygenase-1(HO-1) is the inducible isoform of the rate-limiting enzymatic 
step of heme catabolism and has major antioxidant and anti-inflammatory 
functions. The beneficial effects of this enzyme appear to be mainly mediated via 
degradation of proinflammatory heme and production of the anti-inflammatory 
compounds CO and bilirubin. More recently, myeloid/macrophage cell type 
specific effects of HO-1 have been implicated in central immunomodulatory 
functions of the innate and adaptive immune response. In this thesis 
experimental strategies were used to elucidate the signaling mechanisms 
regulating the HO-1 gene expression. Major results revealed an important role of 
the immunologically relevant kinase Bruton’s tyrosine kinase (Btk) in the 
regulation of TLR-induced signaling of the HO-1 gene and a specific role of the 
p38 MAPK as a repressor of the HO-1 gene in mouse macrophages. TLR ligands, 
specifically the TLR4 ligand LPS induced the activation of the HO-1 gene 
expression via Btk.  Moreover, inhibition of the p38 MAPK induced the HO-1 
gene in cell cultures of macrophages. As revealed in this thesis, both 
mechanisms are mediated at the transcriptional level via the transcription factor 
Nrf2, a crucial regulator of the cellular antioxidant response, and involve ROS as 
signaling molecules.  
4.1 Role of Btk in the induction of the HO-1 gene expression 
The proinflammatory mediator LPS, a ligand of the central macrophage receptor 
TLR4, has previously been shown to induce HO-1 gene expression in 
mononuclear phagocytes (Camhi et al. 1995; Immenschuh et al. 1999; 
Wijayanti et al. 2004). The results of this thesis revealed that inhibition of the 
non-receptor tyrosine kinase Btk by the chemical inhibitor LFM-A13 or genetic 
Btk deficiency blocked the LPS-dependent HO-1 up-regulation in cell cultures of 
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the mouse macrophage cell line RAW264.7 and in murine alveolar macrophages 
(Figs. 7-10). The significance of Btk as an immunologically relevant kinase is 
clearly illustrated in X-linked agammaglobulinemia, a disorder in which a 
mutation of this kinase leads to impaired development of B-cells, making them 
incompetent to produce antibodies  (Vetrie et al. 1993). Although earlier studies 
focussed on the role of this kinase in B-cell function, recent evidences indicated 
that Btk might play an important role in mediating inflammatory responses in 
other cell types, such as macrophages and mast cells (Hata et al. 1998; 
Kawakami et al. 1998; Kawakami et al. 1999; Jefferies and O'Neill 2004). 
Specifically, deficiency of Btk function leads to impaired cytokine response and 
poor nitric oxide induction in response to LPS (Horwood et al. 2003; Mangla et 
al. 2004; Horwood et al. 2006). Moreover, LPS treatment both in vivo and in 
vitro induces the HO-1 gene. Since various studies indicated that LPS-induced 
cytokine and NO production may influence the regulation of the HO-1 gene we 
hypothesized that Btk might also be an upstream candidate in LPS-dependent 
signaling of HO-1 gene up-regulation. The present findings are consistent with 
the notion that Btk might play a central role in mediating the HO-1 gene 
induction by LPS. As the Btk inhibitor LFM-A13 also inhibits the kinase JAK2, Btk 
knockout macrophages were used in this thesis to confirm that the specificity of 
Btk function in HO-1 regulation. Moreover, we have also analysed the effect of 
the JAK2 specific inhibitor AG490 on the regulation of HO-1. In contrast to LFM-
A13, treatment with AG490 alone up-regulated the HO-1 gene expression (Fig. 
7C), indicating that the blockage of the HO-1 gene induction with LFM-A13 is a 
specific effect caused by the inhibition of Btk and not JAK2. However, Btk has 
been shown to be a versatile protein that interacts with many other proteins. 
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Therefore, it is feasible that there might also exist protein-protein interactions 
between JAK2 and Btk, possibly affecting the HO-1 gene regulation. 
4.2 Role of p38 MAPK in the induction of the HO-1 gene expression 
Inhibition of p38 MAPK in monocytic cells by small molecule inhibitors and 
genetic deficiency of p38 in MEFs leads to an increased HO-1gene expression, 
in contrast to an unaltered Cox-2 gene (Fig. 20). Since chemical inhibitors of p38 
MAPK block all four isoforms of this kinase, the specificity for p38was analysed 
in MEFs deficient for p38Because, the induction of HO-1 was observed in both 
RAW264.7 cells and in p38-deficient MEFs in this thesis, it indicates that the 
observed mechanism may not be only restricted to macrophages.  With regard 
to its physiological function p38 seems to be the most important isoform 
among the four p38 family, since the targeted deletion of the p38 gene in mice 
leads to embryonic lethality in mice (Adams et al. 2000). In this respect, it was 
interesting that HO-1 levels were constitutively high in p38-/- MEF, even though 
basal HO-1 expression is generally known to be barely detectable in most cells 
(Maines 1997; Ryter et al. 2006). Moreover, the upregulation of HO-1 by 
inhibition of p38 MAPKs was rather unexpected, since p38 MAPKs has previously 
been shown to mediate the activation of the HO-1 gene in response to various 
stimuli, such as LPS and TPA (Maines 1997; Immenschuh and Ramadori 2000; 
Ryter et al. 2006). Indeed, this has also been reproduced in our study, in which 
induction of HO-1 by TPA was partially blocked after inhibition of p38 MAPKs. 
The findings of this thesis are supported by a recent study demonstrating that 
the basal expression of many genes was increased without the presence of an 
external stress stimulus in immortalized p38-/- cardiomyocytes (Ambrosino et 
al. 2006).  The present observations may therefore suggest that p38 has a dual 
function on the regulation of the HO-1 gene. On the one hand p38 may act as a 
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repressor of HO-1 in unstimulated cells and on the other hand it may promote 
also HO-1 activation in the presence of several external stress stimuli.  
4.3 Transcriptional mode of the HO-1 gene induction  
To investigate if the Btk- and p38-mediated increase of the HO-1 expression 
occurs at the transcriptional level transient transfection experiments with 
reporter gene constructs of the mouse HO-1 gene promoter were performed in 
RAW264.7 cells. Additionally, MEFs were used that were genetically deficient for 
either p38 or Nrf2. Unfortunately, as noted by analysing the effect of LPS on 
MEFs, it was not possible to use appropriate MEFs for studies on Btk, since HO-1 
is not induced by LPS in this cell type (data not shown in Results). 
4.3.1 Transcriptional regulation of the HO-1 gene by Btk   
This is the first report to demonstrate that Btk regulates the redox regulated 
transcription factor Nrf2. Btk had only  been shown before to modulate the 
activity of other transcription factors, including TFII-I and NF-B in B cells 
(Novina et al. 1999; Bajpai et al. 2000) or also NFAT in mast cells (Iwaki et al. 
2005). The immunofluorescense studies showed a decreased nuclear 
translocation of Nrf2 in response to LPS and this indicate that Btk may play a 
role in the LPS mediated activation of Nrf2 
In earlier reports it has been demonstrated that the LPS induced induction of the 
HO-1 gene is mediated by two upstream regions localized at -4kb and -12kb 
relative to the transcription initiation site of the mouse HO-1 gene promoter 
(Camhi et al. 1998). Initially, it was thought that transcriptional regulation via 
these sequences would be regulated by the transcription factor AP-1, because 
both regions contain potential AP-1 sites (Camhi et al. 1995). Later studies, 
however, revealed that these promoter regions are major nuclear targets for the 
transcription factor Nrf2 (Alam et al. 1999). Nrf2 binds to the ARE, also referred 
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to as antioxidant response element or electrophile response element (EpRE), 
several of which are located in the 5'-flanking sequence of the HO-1 gene 
promoter. AREs have been identified in a large number of phase II detoxifying 
enzymes and antioxidant stress proteins (Nguyen et al. 2003). The results of 
this thesis are consistent with this finding and revealed an Nrf2-mediated effect 
on the mouse HO-1 promoter by using reporter gene constructs with the 
proximal 4045 bp of the mouse HO-1 promoter and with ARE. Nrf2 controls the 
HO-1 gene induction in response to various oxidative/stress stimuli and by its 
interaction with keap1 is kept in an inactive state under normal conditions. 
Binding to keap1 in addition marks Nrf2 for proteasomal degradation via 
ubiquitination (Itoh et al. 1999; Kobayashi and Yamamoto 2005; Kensler et al. 
2007). This Btk-mediated Nrf2 activation mechanism does not only regulate the 
HO-1 gene, but is also involved in the LPS-induced up-regulation of the NQO1 
gene, a prototypical Nrf2-regulated gene. Thus, it would raise the possibility that 
also other Nrf2 target genes could also be altered in macrophages. In contrast to 
Nrf2, the transcription factor NF-B, that has been shown earlier to regulate the 
HO-1 gene expression (Wijayanti et al. 2004; Naidu et al. 2008) and is one of 
the classical targets of LPS-dependent TLR4 signaling in mononuclear 
phagocytes, does not seem to play a major role in the HO-1 gene regulation via 
Btk. This assumption is supported by the observations that LPS-dependent 
induction of a NF-B-regulated reporter gene construct (pTNF-585-luc) and 
phosphorylation as well as degradation of the NF-B inhibitor IB were not 
affected by pharmacological inhibition of Btk (Fig. 11). This notion is also in 
agreement with earlier reports, in which it was shown that the Btk-mediated 
induction of TNFα and IL-1ß by LPS was independent of the classical NF-B 
pathway (Horwood et al. 2003; Doyle et al. 2005; Horwood et al. 2006). 
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However, it should be taken into consideration that other transcription factors 
such as AP-1 and USF or the transcription repressor Bach1 might in addition also 
be involved in LPS-mediated HO-1 regulation via Btk (Alam and Cook 2007). 
4.3.2 Transcriptional regulation of the HO-1 gene by p38 inhibitors 
p38 MAPKs regulate gene expression by both transcriptional and post-
transcriptional mechanisms (Ono and Han 2000). Similar to Btk-mediated 
induction of the HO-1 gene, inhibition or genetic deficiency of p38α activates the 
transcription factor Nrf2 for induction of HO-1(Fig 24-25). This conclusion is 
supported by the present finding that genetically deficient p38α MEFs possess 
higher Nrf2 levels in the nucleus. Moreover, Nrf2-deficient MEFs failed to 
upregulate the HO-1 gene after p38 inhibition. In this respect it is of interest 
that the expression of the peroxiredoxin 1 (Prdx1) gene, a gene regulated in a 
similar manner as HO-1 (Immenschuh et al. 1995) was also induced by the 
inhibition of p38. Previously Prdx1 1 has been shown to be a target of Nrf2 
supporting the finding that p38 plays a negative role on Nrf2 activation (Ishii et 
al. 2000). Previous studies have reported that blockage of p38 augments Stress 
response element (StRE)-mediated induction of phase II detoxifying enzymes 
(Yu et al. 2000) and also sulforaphane-dependent activation of HO-1 via Nrf2 in 
human hepatoma HepG2 cells (Keum et al. 2006) and our findings corroborate 
these studies. Finally, it can, however, not be excluded that additional Nrf2-
independent regulatory mechanisms may be involved in the up-regulation of the 
HO-1 gene expression via p38 MAPKs. 
4.4 Signaling pathway  
Btk- and p38α- dependent induction of HO-1 is mediated by distinct signaling 
cascades in macrophages. However, in both of these signaling pathways Nrf2 
and ROS act as downstream regulators of the HO-1 gene expression. 
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4.4.1 Btk-dependent induction of HO-1 gene expression in macrophages 
The results of this thesis indicate that Btk mediates the induction of HO-1 not 
only by stimulation of macrophages via TLR4/LPS, but also by ligands for TLR2, 
TLR7 and TLR9 (Fig. 16-17). These observations are in accordance with earlier 
reports which indicated that Btk might play a central role in macrophage 
stimulation by various TLRs (Koprulu and Ellmeier 2009). As an example, Btk 
has previously been demonstrated to be involved in TLR-dependent induction of 
pro- and anti-inflammatory cytokines (Horwood et al. 2006; Schmidt et al. 
2006). Moreover, Btk has been shown to mediate TLR8- and TLR9-dependent 
signaling in the human macrophage cell line THP-1 (Doyle et al. 2007). The 
current observations of this thesis indicate that ROS may mediate the Btk-
dependent activation of the HO-1 gene expression in TLR-stimulated 
macrophages. These results corroborate earlier findings that ROS generated 
upon TLR4 activation acts as a secondary signaling molecules and mediate 
cellular responses in mononuclear phagocytes (Asehnoune et al. 2004). 
Furthermore, direct interaction of TLR4 and NADPH oxidase 4 (NOX4), has 
previously been shown to mediate generation of ROS in phagocytes (Park et al. 
2004). A similar mechanism has also been reported in an in vivo knockout 
mouse model (Kong et al. 2010). Previously, Mangla and colleagues have 
reported that in Btk-/- mononuclear phagocytes LPS failed to induce ROS 
production (Mangla et al. 2004). Our findings are consistent with this 
observation and further studies are required to characterize the exact 
mechanism by which Btk regulates ROS production in LPS-stimulated 
macrophages. Surprisingly, the present results indicate that Btk-dependent 
induction of the HO-1 gene via Nrf2 is mainly mediated by ROS but not RNS. 
Indeed, the activity of Nrf2 was not influenced by the specific iNOS inhibitor 
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1400W, but blocked by NAC (Fig. 15). However, Nrf2 has previously been shown 
to be activated by NO and reactive nitrogen species in Hela cells (Fourquet et 
al.), human umbilical vein endothelial cells (Heiss et al. 2009) or PC12 
phaeochromocytoma cells (Li et al. 2007). Therefore, it might be feasible that 
cell type- or species-specific effects may play a role in the NO-dependent 
regulation of Nrf2. The Btk-mediated Nrf2 activation may involve direct 
modulation of the cytosolic inhibitor protein Keap1 as described in many 
scenarios (Kobayashi and Yamamoto 2005). Furthermore, ROS produced after 
LPS-induction could in addition regulate gene transcription by other mechanisms 
such as the inhibition of regulatory phosphatases as shown by others (Rhee et 
al. 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30: Model of TLR4 mediated activation of HO-1 gene expression in macrophages 
Upon stimulation with LPS Btk mediates the generation of ROS and that leads to the activation of Nrf2. 
Nrf2 translocates to the nucleus binds to the ARE elements present on HO-1 gene promoter and induce 
the transcription of the HO-1 gene. Whether Btk directly influence NOX enzymes for the generation of 
ROS is not clear and should be explored in further studies. Nrf2: nuclear factor erythroid 2-related factor 
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E2; ARE: antioxidant response element; Keap: Kelch ECH associating protein; ROS: reactive oxygen 
species; sMaf: small Maf protein. 
4.4.2 Regulatory pathways of increased HO-1 gene expression by 
inhibition and genetic deficiency of p38 MAPK 
The results of this thesis revealed that genetic deficiency of p38α causes an 
increase in ERK activity (Fig. 26-27) which is in agreement with an earlier report 
(Porras et al. 2004). Moreover, treatment with the ERK inhibitor PD 98059 in 
p38α-/- MEF abolished the increase in expression of the HO-1 gene indicating that 
the MAPK p38α and ERK play opposing roles in the regulation of this gene. This 
assumption is corroborated by a previous study, in which pharmacological 
inhibition of p38 up-regulated the low density lipoprotein receptor gene 
expression through the activation of ERK in HepG2 cells (Singh et al. 1999). 
Moreover, another independent study has demonstrated that inhibition of p38 
augmented LPS-mediated inducible NO synthase gene expression and NO 
production via JNK activation in macrophages (Lahti et al. 2006). The role of 
MAPK signaling in the regulation of the HO-1 gene is complex and varies among 
species. Elbirt and colleagues reported that in avian hepatocytes both activation 
of ERK and p38 MAPKs were required for the arsenite-dependent induction of the 
HO-1 gene expression (Elbirt et al. 1998). In contrast, both JNK and p38 MAPK 
were important for the HO-1 gene induction by this compound in rat hepatocytes 
(Kietzmann et al. 2003). Thus, one can assume that MAPK modulate HO-1 gene 
expression in a stimulus-, cell- and species-specific manner. 
Since transformed p38α -deficient cells were reported to accumulate much larger 
amounts of ROS than wild type cells, p38α was suggested to play the role of a 
cellular oxidative stress sensor (Dolado et al. 2007). The current findings (Fig. 
28) are in line with this suggestion. Moreover, ROS might be involved in the 
activation of ERK in the absence of  p38 activity (Porras et al. 2004). This is also 
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corroborated by recent reports, which demonstrate that ROS causes a sustained 
activity of ERK in human hepatoma cells (Wu et al. 2006) as well as in a model 
of cerebral ischemia (Wu et al. 2008). Accordingly, this is in line with the results 
obtained in this thesis by treatment of p38α-/- MEF with the antioxidant NAC, 
blocked the increase of the HO-1 gene expression (Fig. 29). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31: Inhibition of p38 activates HO-1 gene expression 
Inhibition or genetic deficiency of p38α MAPK mediates the generation of ROS which leads to the 
activation of Nrf2. Nrf2 translocates to the nucleus binds to the ARE elements present on HO-1 gene 
promoter and induce the transcription of the HO-1 gene. p38α MAPK inhibition also leads to an increase 
in ERK activity which may play a role in this regulatory pathway. Nrf2: nuclear factor erythroid 2-related 
factor E2; ARE: antioxidant response element; Keap: Kelch ECH associating protein; ROS: reactive 
oxygen species; sMaf: small Maf protein. 
 
 
 
4.5 Physiological significance  
4.5.1 Significance of Btk-dependent HO-1 regulation in innate and 
adaptive immune responses 
Btk mutations in humans lead to X-linked agammaglobulinemia (XLA), which is a 
rare genetic immunological disorder (Vetrie et al. 1993) in which the B-cells are 
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not capable to produce antibodies. The phenotype observed in humans can be 
simulated successfully in mice by introducing a  point mutation (R28C) in or by 
targeted disruption of the murine Btk gene (Vetrie et al. 1993; Khan et al. 1995) 
leading to X-linked immunodeficiency (XID). Thus, the blockage of the HO-1 
gene induction in LPS-stimulated Btk-/- macrophages suggests that Btk-
associated immunological defects may be partially caused by the 
immunomodulatory properties of HO-1. This assumption would correspond with 
a recent finding that a myeloid cell-specific knockout of the HO-1 gene impaired 
immunoregulatory functions (Tzima et al. 2009). The IFN-ß signaling pathways 
were severely impaired in these animals, leading to pathological inflammatory 
responses in experimental viral and bacterial infections and in an experimentally 
induced autoimmune encephalomyelitis. The assumption that decreased HO-1 
inducibility in TLR ligand-stimulated macrophages may have profound effects in 
various immune responses also corresponds with one study revealing an 
impairment of TLR-dependent signaling in antigen-presenting cells in patients 
with XLA (Sochorova et al. 2007; Taneichi et al. 2008). Finally, Btk-mediated 
induction of the HO-1 gene may help in the resolution of inflammation by 
regulating the activation of TLR-stimulated macrophages. 
This notion is supported by findings of Nakahira and colleagues who 
demonstrated that LPS-dependent production of CO, the by product of the HO-1 
enzyme reaction forms a negative feedback loop that regulates the translocation 
of TLRs to lipid rafts in macrophages (Nakahira et al. 2006). Finally, an 
interconnection between Btk and HO-1 may also be important for the regulation 
of apoptosis. As mentioned earlier, HO-1 is known to have potent anti-apoptotic 
effects, and in earlier reports it was shown that Btk knockout macrophages 
exhibited an increased rate of apoptosis (Mangla et al. 2004) which might indeed 
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partly be caused by a decreased expression of HO-1. Because of the functional 
relevance of Btk and HO-1 in inflammation, targeted modulation of the related 
signaling pathways in myeloid/macrophage cells may help to develop novel 
therapeutic strategies in the treatment of inflammatory diseases. In conclusion, 
the current study reveals that the increase in HO-1 abundance in TLR-stimulated 
macrophages needs the activation of the Tec family kinase Btk. Due to the vital 
role played by myeloid/macrophage cells in inflammation, the present findings 
provide further insight into the complex signaling pathways regulating the anti-
inflammatory HO-1 gene. 
4.5.2 Physiological significance of HO-1 upregulation mediated by 
inhibition or genetic deficiency of p38 MAPK 
HO-1 is known to have potent anti-apoptotic functions (Ryter et al. 2006),  
increased HO-1 expression levels in p38-/- MEF may partially be involved in the 
observation that p38α deficiency makes these cells more resistant to apoptosis 
via induction of anti-apoptotic genes (Porras et al. 2004). It is also noteworthy 
that degradation of p38α in endothelial cells have been connected with the anti-
apoptotic role of HO-1 (Silva et al. 2006). In summary these findings suggest an 
important relation between HO-1 and p38 regulation. The present thesis 
revealed an activation of the HO-1 gene via pharmacological inhibition or genetic 
deficiency of p38 MAPK. These findings provide new insights into the regulatory 
mechanisms of the HO-1 gene expression in macrophages before and after they 
encounter an inflammatory signal. 
Targeted over expression of HO-1 or induction by potential new drugs might 
open major potentials for the treatment of inflammatory disorders. The salutary 
effects of specific over expression of HO-1 either by pharmacological induction or 
by genetic approaches has been shown in experimental models of various 
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inflammatory disorders such as arthritis, encephalomyelitis and hepatitis (Ryter 
et al. 2006; Vijayan et al. 2010). Furthermore, targeted over expression of HO-1 
in macrophages has also been shown to protect from ischemia-reperfusion injury 
in experimental mouse models of liver and kidney transplantation (Ferenbach et 
al. 2010; Ke et al. 2010). 
4.6 Conclusion 
Unfortunately, the signaling mechanisms leading to the induction of the HO-1 
expression are highly complex, stimuli and cell-type specific. Although HO-1 is 
highly promising as a therapeutic target for intervening inflammation, our 
current knowledge on the complete properties and regulation of the gene HO-1 
still too limited and critical questions remain to be answered before new clinical 
strategies and drug-induced activation of the HO-1 gene might be available for 
severe inflammatory diseases, such as sepsis (Vijayan et al. 2010). 
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5. Summary 
Monocytes or macrophages are crucial regulators of inflammation. Intracellular 
signaling in macrophages is tightly regulated to ensure that they do not undergo 
excessive activation, which may lead to chronic inflammation accompanied with 
potential damage to the host tissue.  Induction of HO-1 in macrophages has 
been shown to have potent immunomodulatory properties. 
In this thesis two different signalling mechanisms are described which lead to 
the induction of HO-1 in macrophages. In the first part the signalling pathway 
leading to the induction of HO-1 via toll-like receptor (TLR)4 by the classical pro-
inflammatory stimulus lipopolysaccharide (LPS) is described. The second part of 
this thesis deals with the induction of HO-1 caused by the inhibition of the 
mitogen activated protein kinase (MAPK) p38. 
Induction of HO-1 by LPS in macrophages has been described earlier, but the 
exact regulatory mechanisms of this pathway are not well understood. In this 
thesis it is shown that Bruton’s tyrosine kinase (Btk) mediates the LPS-induction 
of HO-1. LPS-dependent induction of HO-1 was blocked in macrophages treated 
with the Btk inhibitor, LFM-A13 or in Btk alveolar macrophages. Promoter 
studies and quantitative real time PCR studies revealed a transcriptional 
regulatory mechanism. Btk was shown to mediate the production of ROS and 
activation of the transcription factor Nrf2. 
p38 MAPK inhibition is shown to increase the expression of HO-1. This was 
rather surprising, because activation of p38 MAPK has earlier been shown to 
mediate HO-1 induction caused by various stimuli.  This increase in HO-1 
expression was also observed in p38mouse embryonic fibroblasts. Further 
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analysis revealed that p38 inhibition leads to an increased production of reactive 
oxygen species (ROS) and activation of Nrf2. Furthermore, ERK MAPK was also 
shown to be involved in this pathway. 
Taken together, this thesis demonstrates that signaling to HO-1 in macrophages 
is primarily mediated by the transcription factor Nrf2. Further studies to unravel 
the regulation of this gene may help to develop novel strategies for clinical 
intervention in inflammatory disorders. 
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6. Zussamenfassung 
Monozyten und Makrophagen spielen eine bedeutsame Rolle für die Regulation 
von Entzündungsreaktionen. Die intrazelluläre signaltransduktion in 
Makrophagen wird streng reguliert, um eine überschießende Aktivierung dieser 
Zellen zu vermeiden, die zu einer chronischen Entzündung mit möglicher 
Gewebeschädigung führen könnte. Für die Induktion der Hämoxygenase (HO)-1 
in Makrophagen konnte eine wirksame immunmodulatorische Wirkung gezeigt 
werden. 
In der vorliegenden Arbeit werden zwei verschiedene Signalübertragungwege 
beschrieben, die zu einer Induktion der HO-1 in Makrophagen führen. Im ersten 
Teil der Arbeit ist ein Signalweg beschrieben, der zu einer Induktion der HO-1 
über eine Aktivierung von Toll-like Rezeptor (TLR)-4 durch den klassischen pro-
inflammatorischen Stimulus Lipopolysaccharid (LPS) führt. Der zweite Teil der 
Arbeit beschäftigt sich mit der Induktion der HO-1 durch die Inhibition der 
Mitogen-aktivierten Proteinkinase (MAPK) p38. 
Die Induktion der HO-1 durch LPS wurde bereits früher erstmals beschrieben, 
aber die genauen regulatorischen Mechanismen sind nicht genau bekannt. In der 
vorliegenden Arbeit wurde gezeigt, dass die Bruton-Tyrosinkinase (Btk) die LPS-
abhängige Induktion der HO-1 vermittelt. Die HO-1 Induktion durch LPS wurde 
durch Behandlung von Makrophagen mit dem Btk Inhibitor LFM-A13 oder in Btk-/-  
Alveolarmakrophagen blockiert. Promoterstudien und quantitative real time PCR 
Studien zeigten einen zugrundeliegenden transkriptionalen Mechanismus. 
Weiterhin konnte gezeigt werden, dass die Inhibition der p38 MAPK die HO-1 
Expression heraufreguliert. Dieser Befund war unerwartet, weil in früheren 
Untersuchungen gezeigt worden war, dass p38 Aktivierung die Induktion der 
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HO-1 vermittelt hatte. Diese HO-1 Induktion konnte auch in p38-/- murinen 
embryonalen Fibroblasten beobachtet werden. Weitere Untersuchungen zeigten, 
dass die Inhibition von p38 zu einer gesteigerten Produktion von reaktiven 
Sauerstoffspezies (ROS) und einer Aktivierung von Nrf2 führte. Außerdem 
konnte gezeigt werden, dass die MAPK ERK an dieser Regulation beteiligt war. 
Zusammenfassend zeigt diese Arbeit, dass die signaltransduktion zum HO-1 Gen 
in Makrophagen in erster Linie durch den Transkriptionsfaktor Nrf2 vermittelt 
wird. Weitere Studien zur Aufklärung der genauen Regulation dieses Genes 
könnten dabei helfen, neue Behandlungsstrategien bei der entzündlichen 
Erkrankungen zu entwickeln.  
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7. Appendix 
Plasmids 
BtkDNK430R and BtkDNR28C: 
These Btk dominant negative expression vectors express Btk proteins containing 
mutations which make them non-functional. These plasmid vectors were a 
generous gift from Dr. Sarah Doyle (Trinity College, Dublin, Ireland). The point 
mutations, resulting in either the dominant negative (K430R) or the Xid (R28C) 
version of the Btk protein, were introduced and the sequence was cloned into a 
pCDNA3 expression vector (Jefferies et al. 2003). 
pAP-1 luc: 
pAP-1 luciferase construct (AP-1-Luc) was a generous gift from Dr. Craig A. 
Hauser (The Burnham Institute, La Jolla, CA). This plasmid was generated by 
cloning three AP-1 repeats into a luciferase reporter gene containing a minimal 
Fos promoter (Galang et al. 1994). 
pARE luc: 
pARE-luc contains a copy of the antioxidant response element and was a 
generous gift from Dr. William E. Fahl (University of Wisconsin, Madison, WI, 
USA). It is a TI-luciferase based plasmid which was constructed with either 
double-stranded oligonucleotide or PCR products inserted between the MluI and 
BglII sites of the TI luciferase vector (Wasserman and Fahl 1997). 
pE2 luc: 
pE2-luc was a generous gift from Dr. Jawed Alam (Alton Ochsner Medical Center, 
New Orleans, LS). This plasmid was generated by transferring the HO-1 
enhancer region containing the stress response element and minimal promoter 
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sequences from the corresponding chloramphenicol acetyltransferase reporter 
gene construct pMHO1catD-44 1 AB1 (used in an earlier study), into the 
luciferase reporter plasmid pSKluc (Alam et al. 2000). 
pHO-4045 luc: 
HO-1 luciferase reporter plasmid contains the proximal 4045bp of the mouse 
HO-1 promoter and was a generous gift from Dr. Mark A. Perrella (Harvard 
Medical School, Boston, MS, USA). It was constructed by amplification of HO-1-
(–4045/+74) from the mouse genomic DNA by PCR and then subcloned into the 
pGL2 luciferase reporter vector (Chung et al. 2005). 
pTNF-585-luc: 
This plasmid contains the proximal region of the TNF-alpha promoter which 
consists of two NF-kB elements (Wilson et al. 1997). This plasmid was a 
generous gift from Dr. Gordon Duff (University of Sheffield, Sheffield, UK) which 
was subcloned into a luciferase reporter construct in our lab. 
The other plasmids used in this thesis were purchased from companies as 
mentioned in the Materials and Methods. The details regarding the plasmids can 
be found on the respective company website. 
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9. Index of abbreviations 
AP-1  activator protein-1 
ARE  antioxidant response element 
bZIP  basic leucine zipper 
Btk   Bruton’s tyrosine kinase 
Cox-2  cyclooxygenase-2 
DCFDA dichlorofluorescein diacetate 
DHE   dihydroethidium 
DMEM  Dulbecco’s modified Eagle’s medium 
ERK   extracellular signal-regulated kinase 
FCS   fetal calf serum 
GAPDH  glyceraldehydes-3-phosphate dehydrogenase 
HO  heme oxygenase 
IB  inhibitor of NF-κB 
JNK  c-jun N-terminal kinase 
LFM-A13 α-Cyano-β-hydroxy-β-methyl-N-(2,5-dibromophenyl)propenamide 
LPS  lipopolysaccharide 
MAPKs mitogen activated protein kinases 
MEF  mouse embryonic fibroblast(s) 
MTT   3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
NF-κB  nuclear factor-κB 
NO   nitric oxide 
Nrf2   nuclear factor-erythroid-2 related factor 2 
PBS   phosphate buffered saline 
PMA   phorbol myristate acetate 
Prx   peroxiredoxin 
ROS  reactive oxygen species 
RT  room temperature 
SDS  sodium dodecyl sulfate    
StRE   stress response element 
TLR  toll-like receptor 
TNF-α  tumor necrosis factor-α 
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functions. Although HO-1 has previously been shown to be induced by various stimuli via 
activation of the p38 MAPK signaling pathway, the role of this protein kinase for HO-1 gene 
regulation is largely unknown. In the present study, it is demonstrated that pharmacological 
inhibitors of p38 induced HO-1 expression in monocytic cells. Moreover, basal HO-1 gene 
expression levels were markedly higher in untreated murine embryonic fibroblasts (MEF) 
from p38alpha(-/-) mice compared with those from wild-type mice. Transfection studies with 
106 
 
luciferase reporter gene constructs indicate that increased HO-1 gene expression via 
inhibition of p38 was mediated by the transcription factor Nrf2, which is a central regulator 
of the cellular oxidative stress response. Accordingly, inhibitors of p38 induced binding of 
nuclear proteins to a Nrf2 target sequence of the HO-1 promoter, but did not affect HO-1 
protein expression and promoter activity in Nrf2(-/-) MEF. Genetic deficiency of p38 led to 
enhanced phosphorylation of ERK and increased cellular accumulation of reactive oxygen 
species. In addition, pharmacological blockage of ERK and scavenging of reactive oxygen 
species with N-acetylcysteine reduced HO-1 gene expression in p38(-/-) MEF, respectively. 
Taken together, it is demonstrated that pharmacological inhibition and genetic deficiency of 
p38 induce HO-1 gene expression via a Nrf2-dependent mechanism in monocytic cells and 
MEF. 
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